[{"sessionId":"11045","sessionTitle":"Bone Marrow Failure: Inherited","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"181840","firstName":"Blanche P.","lastName":"Alter"},{"sessionId":"11045","sessionTitle":"Bone Marrow Failure: Inherited","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"181840","firstName":"Blanche P.","lastName":"Alter"},{"sessionId":"11046","sessionTitle":"Bone Marrow Failure: Acquired","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"198574","firstName":"Adrianna","lastName":"Vlachos"},{"sessionId":"11046","sessionTitle":"Bone Marrow Failure: Acquired","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"198574","firstName":"Adrianna","lastName":"Vlachos"},{"sessionId":"11047","sessionTitle":"Management of Sickle Cell Disease: Present and Future","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"194200","firstName":"Mark","lastName":"Gladwin"},{"sessionId":"11047","sessionTitle":"Management of Sickle Cell Disease: Present and Future","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"194200","firstName":"Mark","lastName":"Gladwin"},{"sessionId":"11048","sessionTitle":"Practical Aspects of Acute and Chronic Pain Management in Sickle Cell Disease","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"500745","firstName":"Amanda M.","lastName":"Brandow"},{"sessionId":"11048","sessionTitle":"Practical Aspects of Acute and Chronic Pain Management in Sickle Cell Disease","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"500745","firstName":"Amanda M.","lastName":"Brandow"},{"sessionId":"11049","sessionTitle":"Emerging Issues in Clinical Care in Thalassemia","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"32048","firstName":"Maria Domenica","lastName":"Cappellini"},{"sessionId":"11049","sessionTitle":"Emerging Issues in Clinical Care in Thalassemia","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"32048","firstName":"Maria Domenica","lastName":"Cappellini"},{"sessionId":"11050","sessionTitle":"Congenital and Acquired Neutropenia","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"554684","firstName":"Seth","lastName":"Corey"},{"sessionId":"11050","sessionTitle":"Congenital and Acquired Neutropenia","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"554684","firstName":"Seth","lastName":"Corey"},{"sessionId":"11051","sessionTitle":"Therapeutic Apheresis as an Immunomodulatory Tool","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"562608","firstName":"Jeffrey L.","lastName":"Winters"},{"sessionId":"11051","sessionTitle":"Therapeutic Apheresis as an Immunomodulatory Tool","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"562608","firstName":"Jeffrey L.","lastName":"Winters"},{"sessionId":"11052","sessionTitle":"The Changing Landscape of Hemophilia Therapy","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"551831","firstName":"Margaret V.","lastName":"Ragni"},{"sessionId":"11052","sessionTitle":"The Changing Landscape of Hemophilia Therapy","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"551831","firstName":"Margaret V.","lastName":"Ragni"},{"sessionId":"11053","sessionTitle":"Controversies in Venous Thromboembolism: To Treat or Not to Treat","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"532477","firstName":"Marc","lastName":"Carrier"},{"sessionId":"11053","sessionTitle":"Controversies in Venous Thromboembolism: To Treat or Not to Treat","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"532477","firstName":"Marc","lastName":"Carrier"},{"sessionId":"11054","sessionTitle":"Common Clinical Questions in Cancer-Associated Venous Thromboembolism","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"259455","firstName":"Ingrid","lastName":"Pabinger"},{"sessionId":"11054","sessionTitle":"Common Clinical Questions in Cancer-Associated Venous Thromboembolism","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"259455","firstName":"Ingrid","lastName":"Pabinger"},{"sessionId":"11055","sessionTitle":"Common Hematologic Consults in Pregnancy","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"534","firstName":"Shannon Marie","lastName":"Bates"},{"sessionId":"11055","sessionTitle":"Common Hematologic Consults in Pregnancy","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"534","firstName":"Shannon Marie","lastName":"Bates"},{"sessionId":"11056","sessionTitle":"Thrombocytopenia in Hospitalized Patients","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"170285","firstName":"Lawrence","lastName":"Rice"},{"sessionId":"11056","sessionTitle":"Thrombocytopenia in Hospitalized Patients","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"170285","firstName":"Lawrence","lastName":"Rice"},{"sessionId":"11057","sessionTitle":"Thrombosis, Devices, and Interventions","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"501625","firstName":"Leslie J.","lastName":"Raffini"},{"sessionId":"11057","sessionTitle":"Thrombosis, Devices, and Interventions","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"501625","firstName":"Leslie J.","lastName":"Raffini"},{"sessionId":"11058","sessionTitle":"It All Starts Here: Disorders of Primary Hemostasis","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"527896","firstName":"Cindy","lastName":"Neunert"},{"sessionId":"11058","sessionTitle":"It All Starts Here: Disorders of Primary Hemostasis","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"527896","firstName":"Cindy","lastName":"Neunert"},{"sessionId":"11059","sessionTitle":"Lessons Learned From Quality Improvement Initiatives in Sickle Cell Disease","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"197815","firstName":"Joshua J.","lastName":"Field"},{"sessionId":"11059","sessionTitle":"Lessons Learned From Quality Improvement Initiatives in Sickle Cell Disease","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"197815","firstName":"Joshua J.","lastName":"Field"},{"sessionId":"11060","sessionTitle":"Emerging Pathogens from A to Zika and Their Impact on Transfusion Safety","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"160562","firstName":"Michael Paul","lastName":"Busch"},{"sessionId":"11061","sessionTitle":"A Sticky Business: New Insights Into Neutrophil Extracellular Traps (NETs) in Physiology and Disease","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"566646","firstName":"Mary C","lastName":"Dinauer"},{"sessionId":"11062","sessionTitle":"Debate: Patients With Acquired TTP in Remission Should Be Treated to Prevent Relapse","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"259282","firstName":"J. Evan","lastName":"Sadler"},{"sessionId":"11063","sessionTitle":"Getting Patients to Transplant: Myths and Reality","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"213032","firstName":"Krishna V.","lastName":"Komanduri"},{"sessionId":"11064","sessionTitle":"Novel Epigenetic Modifications in Cancer and Development","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"259122","firstName":"Grant A.","lastName":"Challen"},{"sessionId":"11064","sessionTitle":"Novel Epigenetic Modifications in Cancer and Development","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"259122","firstName":"Grant A.","lastName":"Challen"},{"sessionId":"11065","sessionTitle":"Primary Immunodeficiencies From Childhood to Adulthood","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"221969","firstName":"Marina","lastName":"Cavazzana"},{"sessionId":"11065","sessionTitle":"Primary Immunodeficiencies From Childhood to Adulthood","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"221969","firstName":"Marina","lastName":"Cavazzana"},{"sessionId":"11066","sessionTitle":"Genetic Pathways That Disrupt Hematopoietic Stem Cell Function in Inherited Bone Marrow Failure","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"562540","firstName":"Colin A.","lastName":"Sieff"},{"sessionId":"11066","sessionTitle":"Genetic Pathways That Disrupt Hematopoietic Stem Cell Function in Inherited Bone Marrow Failure","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"562540","firstName":"Colin A.","lastName":"Sieff"},{"sessionId":"11067","sessionTitle":"Next-Generation Sequencing in Routine Diagnostics: Are We There Yet?","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"562541","firstName":"Maria A.","lastName":"Proytcheva"},{"sessionId":"11067","sessionTitle":"Next-Generation Sequencing in Routine Diagnostics: Are We There Yet?","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"562541","firstName":"Maria A.","lastName":"Proytcheva"},{"sessionId":"11068","sessionTitle":"Hematopoietic Stem Cell Generation: Reprogramming and Expansion","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"225270","firstName":"Warren S.","lastName":"Alexander"},{"sessionId":"11068","sessionTitle":"Hematopoietic Stem Cell Generation: Reprogramming and Expansion","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"225270","firstName":"Warren S.","lastName":"Alexander"},{"sessionId":"11069","sessionTitle":"Impact of the Contact Pathway on Disease States: Molecular Mechanisms","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"556004","firstName":"Rodney M.","lastName":"Camire"},{"sessionId":"11069","sessionTitle":"Impact of the Contact Pathway on Disease States: Molecular Mechanisms","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"556004","firstName":"Rodney M.","lastName":"Camire"},{"sessionId":"11070","sessionTitle":"New Approaches to Understanding Microbial Immune System Interactions","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"190859","firstName":"Jonathan S.","lastName":"Serody"},{"sessionId":"11070","sessionTitle":"New Approaches to Understanding Microbial Immune System Interactions","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"190859","firstName":"Jonathan S.","lastName":"Serody"},{"sessionId":"11071","sessionTitle":"Iron Trafficking: Ins and Outs in Organelles, Organs, and Organisms","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"193732","firstName":"Martina","lastName":"Muckenthaler"},{"sessionId":"11071","sessionTitle":"Iron Trafficking: Ins and Outs in Organelles, Organs, and Organisms","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"193732","firstName":"Martina","lastName":"Muckenthaler"},{"sessionId":"11072","sessionTitle":"Advances in Cellular Immunotherapy for Lymphoid Malignancies","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"501235","firstName":"Adolfo A.","lastName":"Ferrando"},{"sessionId":"11072","sessionTitle":"Advances in Cellular Immunotherapy for Lymphoid Malignancies","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"501235","firstName":"Adolfo A.","lastName":"Ferrando"},{"sessionId":"11073","sessionTitle":"New Innovations in Platelet Regulation of Tumor Growth and Metastasis","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"531606","firstName":"Michael","lastName":"Holinstat"},{"sessionId":"11073","sessionTitle":"New Innovations in Platelet Regulation of Tumor Growth and Metastasis","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"531606","firstName":"Michael","lastName":"Holinstat"},{"sessionId":"11074","sessionTitle":"Clonal Evolution in Myeloid Malignancies","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:30:00 AM","sessionPerson":"155722","firstName":"Reuben","lastName":"Kapur"},{"sessionId":"11074","sessionTitle":"Clonal Evolution in Myeloid Malignancies","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:30:00 AM","sessionPerson":"155722","firstName":"Reuben","lastName":"Kapur"},{"sessionId":"11074","sessionTitle":"Clonal Evolution in Myeloid Malignancies","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:30:00 AM","sessionPerson":"156533","firstName":"Lucy A.","lastName":"Godley"},{"sessionId":"11074","sessionTitle":"Clonal Evolution in Myeloid Malignancies","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:30:00 AM","sessionPerson":"156533","firstName":"Lucy A.","lastName":"Godley"},{"sessionId":"11075","sessionTitle":"The Yin and Yang of Myeloma: Understanding and Harnessing Normal Plasma Cell Biology to Better Treat Myeloma","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"148865","firstName":"Rafael","lastName":"Fonseca"},{"sessionId":"11075","sessionTitle":"The Yin and Yang of Myeloma: Understanding and Harnessing Normal Plasma Cell Biology to Better Treat Myeloma","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"148865","firstName":"Rafael","lastName":"Fonseca"},{"sessionId":"11077","sessionTitle":"Presidential Symposium","sessionStartTime":"9:45:00 AM","sessionEndTime":"11:15:00 AM","sessionPerson":"574592","firstName":"Kenneth C.","lastName":"Anderson"},{"sessionId":"11078","sessionTitle":"ASH-EHA Joint Symposium","sessionStartTime":"12:30:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"574592","firstName":"Kenneth C.","lastName":"Anderson"},{"sessionId":"11078","sessionTitle":"ASH-EHA Joint Symposium","sessionStartTime":"12:30:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"148939","firstName":"Pieter","lastName":"Sonneveld"},{"sessionId":"11081","sessionTitle":"ASH Practice Partnership Lunch","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:30:00 PM","sessionPerson":"206","firstName":"Joseph","lastName":"Alvarnas"},{"sessionId":"11083","sessionTitle":"Special Symposium on Quality","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"562542","firstName":"Colleen","lastName":"Morton"},{"sessionId":"11083","sessionTitle":"Special Symposium on Quality","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"212370","firstName":"William A.","lastName":"Wood"},{"sessionId":"11084","sessionTitle":"ASH Choosing Wisely® Campaign: 2017 ASH Choosing Wisely Champions","sessionStartTime":"12:15:00 PM","sessionEndTime":"1:15:00 PM","sessionPerson":"228952","firstName":"Lisa K.","lastName":"Hicks"},{"sessionId":"11085","sessionTitle":"Special Education Session on New ASH Clinical Practice Guidelines on Venous Thromboembolism","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"533488","firstName":"Adam","lastName":"Cuker"},{"sessionId":"11085","sessionTitle":"Special Education Session on New ASH Clinical Practice Guidelines on Venous Thromboembolism","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"562543","firstName":"Holger","lastName":"Schünemann"},{"sessionId":"11086","sessionTitle":"Quality Conversations on Social Media: Achieving Credibility and Efficiency Together","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"8764","firstName":"Joseph R.","lastName":"Mikhael"},{"sessionId":"11087","sessionTitle":"AML MATTERS: A Multidisciplinary Approach To Testing and Diagnosis, Evaluation of Risk, and Personalized Treatment Selection","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"565783","firstName":"Jessica K.","lastName":"Altman"},{"sessionId":"11088","sessionTitle":"Global Hematology Symposium","sessionStartTime":"12:15:00 PM","sessionEndTime":"1:15:00 PM","sessionPerson":"501004","firstName":"Leslie","lastName":"Kean"},{"sessionId":"11088","sessionTitle":"Global Hematology Symposium","sessionStartTime":"12:15:00 PM","sessionEndTime":"1:15:00 PM","sessionPerson":"601296","firstName":"Kwaku","lastName":"Ohene-Frempong"},{"sessionId":"11089","sessionTitle":"Blood and Beyond: The Art of Perception","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"199045","firstName":"Bob","lastName":"Löwenberg"},{"sessionId":"11090","sessionTitle":"When Graft Versus Tumor Fails: The Biology and Treatment of Relapse After Allogeneic Stem Cell Transplantation","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"161247","firstName":"Mohamad","lastName":"Mohty"},{"sessionId":"11090","sessionTitle":"When Graft Versus Tumor Fails: The Biology and Treatment of Relapse After Allogeneic Stem Cell Transplantation","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"161247","firstName":"Mohamad","lastName":"Mohty"},{"sessionId":"11091","sessionTitle":"Dilemmas in Pediatric Hematologic Malignancy","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"562478","firstName":"Lewis B.","lastName":"Silverman"},{"sessionId":"11091","sessionTitle":"Dilemmas in Pediatric Hematologic Malignancy","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"562478","firstName":"Lewis B.","lastName":"Silverman"},{"sessionId":"11092","sessionTitle":"Novel Therapeutics in Myeloma","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"561939","firstName":"Maria-Victoria","lastName":"Mateos"},{"sessionId":"11092","sessionTitle":"Novel Therapeutics in Myeloma","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"561939","firstName":"Maria-Victoria","lastName":"Mateos"},{"sessionId":"11093","sessionTitle":"Controversies in Myeloma","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"574399","firstName":"Ola","lastName":"Landgren"},{"sessionId":"11093","sessionTitle":"Controversies in Myeloma","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"574399","firstName":"Ola","lastName":"Landgren"},{"sessionId":"11094","sessionTitle":"Myelodysplastic Syndromes: Understanding the Current Treatment Landscape","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"259407","firstName":"Olatoyosi","lastName":"Odenike"},{"sessionId":"11094","sessionTitle":"Myelodysplastic Syndromes: Understanding the Current Treatment Landscape","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"259407","firstName":"Olatoyosi","lastName":"Odenike"},{"sessionId":"11095","sessionTitle":"Myeloproliferative Neoplasms: New Insights in the Current Treatment Paradigm","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"221542","firstName":"Alessandro M.","lastName":"Vannucchi"},{"sessionId":"11095","sessionTitle":"Myeloproliferative Neoplasms: New Insights in the Current Treatment Paradigm","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"221542","firstName":"Alessandro M.","lastName":"Vannucchi"},{"sessionId":"11096","sessionTitle":"Chronic Myeloid Leukemia: Where Are We in the Current TKI Era?","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"561820","firstName":"Francois-Xavier","lastName":"Mahon"},{"sessionId":"11096","sessionTitle":"Chronic Myeloid Leukemia: Where Are We in the Current TKI Era?","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"561820","firstName":"Francois-Xavier","lastName":"Mahon"},{"sessionId":"11097","sessionTitle":"Acute Lymphocytic Leukemia: New Approaches in Management","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"575290","firstName":"Wendy","lastName":"Stock"},{"sessionId":"11097","sessionTitle":"Acute Lymphocytic Leukemia: New Approaches in Management","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"575290","firstName":"Wendy","lastName":"Stock"},{"sessionId":"11098","sessionTitle":"Acute Myeloid Leukemia: How Can We Improve Upon “Standard” Therapy?","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"198350","firstName":"Selina M.","lastName":"Luger"},{"sessionId":"11098","sessionTitle":"Acute Myeloid Leukemia: How Can We Improve Upon “Standard” Therapy?","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"198350","firstName":"Selina M.","lastName":"Luger"},{"sessionId":"11099","sessionTitle":"Individualizing Therapy in Chronic Lymphocytic Leukemia","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"561667","firstName":"Matthew S.","lastName":"Davids"},{"sessionId":"11099","sessionTitle":"Individualizing Therapy in Chronic Lymphocytic Leukemia","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"561667","firstName":"Matthew S.","lastName":"Davids"},{"sessionId":"11100","sessionTitle":"The Challenge of Primary and Secondary Central Nervous System Lymphoma","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"260007","firstName":"James L.","lastName":"Rubenstein"},{"sessionId":"11100","sessionTitle":"The Challenge of Primary and Secondary Central Nervous System Lymphoma","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"260007","firstName":"James L.","lastName":"Rubenstein"},{"sessionId":"11101","sessionTitle":"The Expanding Role of Immunotherapy in Non-Hodgkin Lymphoma","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"260008","firstName":"Stephen M.","lastName":"Ansell"},{"sessionId":"11101","sessionTitle":"The Expanding Role of Immunotherapy in Non-Hodgkin Lymphoma","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"260008","firstName":"Stephen M.","lastName":"Ansell"},{"sessionId":"11102","sessionTitle":"Evolving Strategies in Aggressive B-Cell Lymphoma","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"196488","firstName":"Kieron","lastName":"Dunleavy"},{"sessionId":"11102","sessionTitle":"Evolving Strategies in Aggressive B-Cell Lymphoma","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"196488","firstName":"Kieron","lastName":"Dunleavy"},{"sessionId":"11103","sessionTitle":"Hodgkin Lymphoma: New Insights and New Approaches","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"536769","firstName":"Nancy L.","lastName":"Bartlett"},{"sessionId":"11103","sessionTitle":"Hodgkin Lymphoma: New Insights and New Approaches","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"536769","firstName":"Nancy L.","lastName":"Bartlett"},{"sessionId":"11104","sessionTitle":"Indolent Lymphoma: How Understanding Disease Biology Is Influencing Clinical Decision-Making","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"537512","firstName":"Brad S.","lastName":"Kahl"},{"sessionId":"11104","sessionTitle":"Indolent Lymphoma: How Understanding Disease Biology Is Influencing Clinical Decision-Making","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"537512","firstName":"Brad S.","lastName":"Kahl"},{"sessionId":"11105","sessionTitle":"Identification and Management of Toxicities Induced by Immunotherapies","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"547329","firstName":"Helen E.","lastName":"Heslop"},{"sessionId":"11106","sessionTitle":"Editing and Enhancing Erythropoiesis","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"562272","firstName":"Merav","lastName":"Socolovsky"},{"sessionId":"11106","sessionTitle":"Editing and Enhancing Erythropoiesis","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"562272","firstName":"Merav","lastName":"Socolovsky"},{"sessionId":"11107","sessionTitle":"Evolving Approaches to Gene Therapy for Blood Diseases","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"177189","firstName":"Hans-Peter","lastName":"Kiem"},{"sessionId":"11107","sessionTitle":"Evolving Approaches to Gene Therapy for Blood Diseases","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"177189","firstName":"Hans-Peter","lastName":"Kiem"},{"sessionId":"11108","sessionTitle":"Thrombosis: A View From the World of Bioengineering","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"259244","firstName":"David A.","lastName":"Garcia"},{"sessionId":"11108","sessionTitle":"Thrombosis: A View From the World of Bioengineering","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"259244","firstName":"David A.","lastName":"Garcia"},{"sessionId":"11109","sessionTitle":"Targeted for Destruction: Clearance and Hemostatic Activity of Endogenous and Transfused Platelets","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"562544","firstName":"Martin L.","lastName":"Olsson"},{"sessionId":"11109","sessionTitle":"Targeted for Destruction: Clearance and Hemostatic Activity of Endogenous and Transfused Platelets","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"562544","firstName":"Martin L.","lastName":"Olsson"},{"sessionId":"11110","sessionTitle":"Targeting T-Cell Exhaustion","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"562545","firstName":"W. Nicholas","lastName":"Haining"},{"sessionId":"11110","sessionTitle":"Targeting T-Cell Exhaustion","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"562545","firstName":"W. Nicholas","lastName":"Haining"},{"sessionId":"11111","sessionTitle":"Special Scientific Symposium on Targeted Therapy: What Is the Best Target?","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"534128","firstName":"Ross L.","lastName":"Levine"},{"sessionId":"11112","sessionTitle":"Special Scientific Symposium on Understanding and Modulating the DNA Damage Response","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"518134","firstName":"Alan D.","lastName":"D'Andrea"},{"sessionId":"11113","sessionTitle":"Special Symposium on the Basic Science of Hemostasis and Thrombosis","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:30:00 PM","sessionPerson":"556004","firstName":"Rodney M.","lastName":"Camire"},{"sessionId":"11113","sessionTitle":"Special Symposium on the Basic Science of Hemostasis and Thrombosis","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:30:00 PM","sessionPerson":"531606","firstName":"Michael","lastName":"Holinstat"},{"sessionId":"11113","sessionTitle":"Special Symposium on the Basic Science of Hemostasis and Thrombosis","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:30:00 PM","sessionPerson":"259244","firstName":"David A.","lastName":"Garcia"},{"sessionId":"11114","sessionTitle":"Special Scientific Symposium on Hot Topics in Hematology: New Pathways Linking Hematopoiesis, Thrombosis, and Cardiovascular Disease","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"8753","firstName":"Cynthia E.","lastName":"Dunbar"},{"sessionId":"11115","sessionTitle":"The Impact of the Microbiome on the Hematologic System: Thrombosis and Graft-Versus-Host Disease","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"258849","firstName":"Ami S.","lastName":"Bhatt"},{"sessionId":"11116","sessionTitle":"Beyond Sequencing: Emerging Tools for Analysis of Multi-Omic Genomic Data in Acquired and Inherited Hematologic Disease","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"562312","firstName":"Paul F.","lastName":"Bray"},{"sessionId":"11139","sessionTitle":"Trainee Day Didactic Session 1: Statistics and Trial Design","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:15:00 PM","sessionPerson":"501294","firstName":"Alison W.","lastName":"Loren"},{"sessionId":"11159","sessionTitle":"Trainee Didactic Session: Time Management and Balance","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"518724","firstName":"Angela R.","lastName":"Smith"},{"sessionId":"11166","sessionTitle":"K2R: Breakout 1: Basic Science","sessionStartTime":"2:30:00 PM","sessionEndTime":"4:00:00 PM","sessionPerson":"53371","firstName":"Martha P.","lastName":"Mims"},{"sessionId":"11166","sessionTitle":"K2R: Breakout 1: Basic Science","sessionStartTime":"2:30:00 PM","sessionEndTime":"4:00:00 PM","sessionPerson":"537491","firstName":"Joseph E.","lastName":"Italiano Jr."},{"sessionId":"11166","sessionTitle":"K2R: Breakout 1: Basic Science","sessionStartTime":"2:30:00 PM","sessionEndTime":"4:00:00 PM","sessionPerson":"562033","firstName":"Janis L.","lastName":"Abkowitz"},{"sessionId":"11168","sessionTitle":"K2R: Breakout 2: Clinical","sessionStartTime":"2:30:00 PM","sessionEndTime":"4:00:00 PM","sessionPerson":"279802","firstName":"Terry B.","lastName":"Gernsheimer"},{"sessionId":"11168","sessionTitle":"K2R: Breakout 2: Clinical","sessionStartTime":"2:30:00 PM","sessionEndTime":"4:00:00 PM","sessionPerson":"547329","firstName":"Helen E.","lastName":"Heslop"},{"sessionId":"11169","sessionTitle":"K2R: Breakout 3: Education/ Epidemiology/ Health Services","sessionStartTime":"2:30:00 PM","sessionEndTime":"4:00:00 PM","sessionPerson":"534425","firstName":"Ayalew","lastName":"Tefferi"},{"sessionId":"11169","sessionTitle":"K2R: Breakout 3: Education/ Epidemiology/ Health Services","sessionStartTime":"2:30:00 PM","sessionEndTime":"4:00:00 PM","sessionPerson":"158654","firstName":"Scott D.","lastName":"Gitlin"},{"sessionId":"11170","sessionTitle":"K2R: Panel Discussion: The Dollars and Sense of Pursuing an Academic Career: Your First Academic Position ","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:00:00 PM","sessionPerson":"537491","firstName":"Joseph E.","lastName":"Italiano Jr."},{"sessionId":"11170","sessionTitle":"K2R: Panel Discussion: The Dollars and Sense of Pursuing an Academic Career: Your First Academic Position ","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:00:00 PM","sessionPerson":"562033","firstName":"Janis L.","lastName":"Abkowitz"},{"sessionId":"11170","sessionTitle":"K2R: Panel Discussion: The Dollars and Sense of Pursuing an Academic Career: Your First Academic Position ","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:00:00 PM","sessionPerson":"279802","firstName":"Terry B.","lastName":"Gernsheimer"},{"sessionId":"11170","sessionTitle":"K2R: Panel Discussion: The Dollars and Sense of Pursuing an Academic Career: Your First Academic Position ","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:00:00 PM","sessionPerson":"547329","firstName":"Helen E.","lastName":"Heslop"},{"sessionId":"11170","sessionTitle":"K2R: Panel Discussion: The Dollars and Sense of Pursuing an Academic Career: Your First Academic Position ","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:00:00 PM","sessionPerson":"534425","firstName":"Ayalew","lastName":"Tefferi"},{"sessionId":"11170","sessionTitle":"K2R: Panel Discussion: The Dollars and Sense of Pursuing an Academic Career: Your First Academic Position ","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:00:00 PM","sessionPerson":"158654","firstName":"Scott D.","lastName":"Gitlin"},{"sessionId":"11177","sessionTitle":"Hematology Course Directors’ Workshop","sessionStartTime":"7:00:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"536178","firstName":"Leslie Renee","lastName":"Ellis"},{"sessionId":"11178","sessionTitle":"Junior Faculty Development  Education Session: Grant Funding: How to Get It and How to Keep It Going","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"259804","firstName":"Rebecca L.","lastName":"Olin"},{"sessionId":"11181","sessionTitle":"Career Development Lunch Sessions: Room 1","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"534308","firstName":"Jennifer C.","lastName":"Kesselheim"},{"sessionId":"11217","sessionTitle":"Networking Reception for Female Hematologists","sessionStartTime":"7:30:00 PM","sessionEndTime":"9:00:00 PM","sessionPerson":"537238","firstName":"Christine","lastName":"Chomienne"},{"sessionId":"11217","sessionTitle":"Networking Reception for Female Hematologists","sessionStartTime":"7:30:00 PM","sessionEndTime":"9:00:00 PM","sessionPerson":"540460","firstName":"Linda J.","lastName":"Burns"},{"sessionId":"11217","sessionTitle":"Networking Reception for Female Hematologists","sessionStartTime":"7:30:00 PM","sessionEndTime":"9:00:00 PM","sessionPerson":"540460","firstName":"Linda J.","lastName":"Burns"},{"sessionId":"11217","sessionTitle":"Networking Reception for Female Hematologists","sessionStartTime":"7:30:00 PM","sessionEndTime":"9:00:00 PM","sessionPerson":"537238","firstName":"Christine","lastName":"Chomienne"},{"sessionId":"11220","sessionTitle":"Announcement of Awards: William Dameshek Prize and Henry M. Stratton Medal","sessionStartTime":"9:30:00 AM","sessionEndTime":"9:45:00 AM","sessionPerson":"574592","firstName":"Kenneth C.","lastName":"Anderson"},{"sessionId":"11220","sessionTitle":"Announcement of Awards: William Dameshek Prize and Henry M. Stratton Medal","sessionStartTime":"9:30:00 AM","sessionEndTime":"9:45:00 AM","sessionPerson":"534434","firstName":"Benjamin L.","lastName":"Ebert"},{"sessionId":"11220","sessionTitle":"Announcement of Awards: William Dameshek Prize and Henry M. Stratton Medal","sessionStartTime":"9:30:00 AM","sessionEndTime":"9:45:00 AM","sessionPerson":"507021","firstName":"Sherrill J.","lastName":"Slichter"},{"sessionId":"11220","sessionTitle":"Announcement of Awards: William Dameshek Prize and Henry M. Stratton Medal","sessionStartTime":"9:30:00 AM","sessionEndTime":"9:45:00 AM","sessionPerson":"562222","firstName":"Josef T.","lastName":"Prchal"},{"sessionId":"11224","sessionTitle":"Announcement of Awards: ASH Mentor Awards, ASH Award for Leadership in Promoting Diversity, ASH Outstanding Service Award, ASH Public Service Award, and Wallace H. Coulter Award for Lifetime Achievement in Hematology","sessionStartTime":"1:30:00 PM","sessionEndTime":"2:00:00 PM","sessionPerson":"574592","firstName":"Kenneth C.","lastName":"Anderson"},{"sessionId":"11224","sessionTitle":"Announcement of Awards: ASH Mentor Awards, ASH Award for Leadership in Promoting Diversity, ASH Outstanding Service Award, ASH Public Service Award, and Wallace H. Coulter Award for Lifetime Achievement in Hematology","sessionStartTime":"1:30:00 PM","sessionEndTime":"2:00:00 PM","sessionPerson":"3247","firstName":"Ronald","lastName":"Hoffman"},{"sessionId":"11224","sessionTitle":"Announcement of Awards: ASH Mentor Awards, ASH Award for Leadership in Promoting Diversity, ASH Outstanding Service Award, ASH Public Service Award, and Wallace H. Coulter Award for Lifetime Achievement in Hematology","sessionStartTime":"1:30:00 PM","sessionEndTime":"2:00:00 PM","sessionPerson":"209779","firstName":"Oliver W.","lastName":"Press"},{"sessionId":"11224","sessionTitle":"Announcement of Awards: ASH Mentor Awards, ASH Award for Leadership in Promoting Diversity, ASH Outstanding Service Award, ASH Public Service Award, and Wallace H. Coulter Award for Lifetime Achievement in Hematology","sessionStartTime":"1:30:00 PM","sessionEndTime":"2:00:00 PM","sessionPerson":"561438","firstName":"Betty S.","lastName":"Pace"},{"sessionId":"11224","sessionTitle":"Announcement of Awards: ASH Mentor Awards, ASH Award for Leadership in Promoting Diversity, ASH Outstanding Service Award, ASH Public Service Award, and Wallace H. Coulter Award for Lifetime Achievement in Hematology","sessionStartTime":"1:30:00 PM","sessionEndTime":"2:00:00 PM","sessionPerson":"4491","firstName":"Marshall A.","lastName":"Lichtman"},{"sessionId":"11231","sessionTitle":"Training Program Directors’ Workshop","sessionStartTime":"12:00:00 PM","sessionEndTime":"5:00:00 PM","sessionPerson":"501609","firstName":"Ann S.","lastName":"LaCasce"},{"sessionId":"11243","sessionTitle":"How to Get Published in a Peer-Reviewed Journal","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"555042","firstName":"Bob","lastName":"Lowenberg"},{"sessionId":"11245","sessionTitle":"Meet the Blood Editors","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"542268","firstName":"Thomas L.","lastName":"Ortel"},{"sessionId":"11245","sessionTitle":"Meet the Blood Editors","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"538593","firstName":"David M.","lastName":"Bodine"},{"sessionId":"11246","sessionTitle":"Meet the Blood Editors","sessionStartTime":"12:15:00 PM","sessionEndTime":"1:15:00 PM","sessionPerson":"134390","firstName":"Nancy","lastName":"Berliner"},{"sessionId":"11246","sessionTitle":"Meet the Blood Editors","sessionStartTime":"12:15:00 PM","sessionEndTime":"1:15:00 PM","sessionPerson":"531724","firstName":"Jose A.","lastName":"Lopez"},{"sessionId":"11316","sessionTitle":"Consultative Hematology Course","sessionStartTime":"7:00:00 AM","sessionEndTime":"11:30:00 AM","sessionPerson":"198162","firstName":"Michael","lastName":"Linenberger"},{"sessionId":"11316","sessionTitle":"Consultative Hematology Course","sessionStartTime":"7:00:00 AM","sessionEndTime":"11:30:00 AM","sessionPerson":"3509","firstName":"Paula D.","lastName":"James"},{"sessionId":"11338","sessionTitle":"Continuing Conversations With the Speakers on Novel Epigenetic Modifications in Cancer and Development","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"259122","firstName":"Grant A.","lastName":"Challen"},{"sessionId":"11338","sessionTitle":"Continuing Conversations With the Speakers on Novel Epigenetic Modifications in Cancer and Development","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"204570","firstName":"Maria E.","lastName":"Figueroa"},{"sessionId":"11338","sessionTitle":"Continuing Conversations With the Speakers on Novel Epigenetic Modifications in Cancer and Development","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"562710","firstName":"Anjana","lastName":"Rao"},{"sessionId":"11338","sessionTitle":"Continuing Conversations With the Speakers on Novel Epigenetic Modifications in Cancer and Development","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"562839","firstName":"Frank","lastName":"Lyko"},{"sessionId":"11339","sessionTitle":"Continuing Conversations With the Speakers on Clonal Evolution in Myeloid Malignancies","sessionStartTime":"11:45:00 AM","sessionEndTime":"12:45:00 PM","sessionPerson":"155722","firstName":"Reuben","lastName":"Kapur"},{"sessionId":"11339","sessionTitle":"Continuing Conversations With the Speakers on Clonal Evolution in Myeloid Malignancies","sessionStartTime":"11:45:00 AM","sessionEndTime":"12:45:00 PM","sessionPerson":"156533","firstName":"Lucy A.","lastName":"Godley"},{"sessionId":"11339","sessionTitle":"Continuing Conversations With the Speakers on Clonal Evolution in Myeloid Malignancies","sessionStartTime":"11:45:00 AM","sessionEndTime":"12:45:00 PM","sessionPerson":"562715","firstName":"Christina","lastName":"Curtis"},{"sessionId":"11339","sessionTitle":"Continuing Conversations With the Speakers on Clonal Evolution in Myeloid Malignancies","sessionStartTime":"11:45:00 AM","sessionEndTime":"12:45:00 PM","sessionPerson":"193779","firstName":"Timothy J.","lastName":"Ley"},{"sessionId":"11339","sessionTitle":"Continuing Conversations With the Speakers on Clonal Evolution in Myeloid Malignancies","sessionStartTime":"11:45:00 AM","sessionEndTime":"12:45:00 PM","sessionPerson":"561656","firstName":"Daniel C.","lastName":"Link"},{"sessionId":"11339","sessionTitle":"Continuing Conversations With the Speakers on Clonal Evolution in Myeloid Malignancies","sessionStartTime":"11:45:00 AM","sessionEndTime":"12:45:00 PM","sessionPerson":"562652","firstName":"Anna L.","lastName":"Brown"},{"sessionId":"11341","sessionTitle":"Continuing Conversations With the Speakers on Advances in Cellular Immunotherapy for Lymphoid Malignancies","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"501235","firstName":"Adolfo A.","lastName":"Ferrando"},{"sessionId":"11341","sessionTitle":"Continuing Conversations With the Speakers on Advances in Cellular Immunotherapy for Lymphoid Malignancies","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"562649","firstName":"Gianpietro","lastName":"Dotti"},{"sessionId":"11341","sessionTitle":"Continuing Conversations With the Speakers on Advances in Cellular Immunotherapy for Lymphoid Malignancies","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"562650","firstName":"Cameron J.","lastName":"Turtle"},{"sessionId":"11341","sessionTitle":"Continuing Conversations With the Speakers on Advances in Cellular Immunotherapy for Lymphoid Malignancies","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"259560","firstName":"Crystal L.","lastName":"Mackall"},{"sessionId":"11344","sessionTitle":"Continuing Conversations With the Speakers on New Innovations in Platelet Regulation of Tumor Growth and Metastasis","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"531606","firstName":"Michael","lastName":"Holinstat"},{"sessionId":"11344","sessionTitle":"Continuing Conversations With the Speakers on New Innovations in Platelet Regulation of Tumor Growth and Metastasis","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"259101","firstName":"Tatiana V.","lastName":"Byzova"},{"sessionId":"11344","sessionTitle":"Continuing Conversations With the Speakers on New Innovations in Platelet Regulation of Tumor Growth and Metastasis","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"130745","firstName":"Elisabeth M.","lastName":"Battinelli"},{"sessionId":"11344","sessionTitle":"Continuing Conversations With the Speakers on New Innovations in Platelet Regulation of Tumor Growth and Metastasis","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"259103","firstName":"Anil","lastName":"Sood"},{"sessionId":"11346","sessionTitle":"Plasma Cells and Myeloma","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"501405","firstName":"Lawrence H.","lastName":"Boise"},{"sessionId":"11347","sessionTitle":"Platelet Clearance","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"205242","firstName":"Karin M.","lastName":"Hoffmeister"},{"sessionId":"11349","sessionTitle":"Contact Pathways in Health and Disease","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"500752","firstName":"James H.","lastName":"Morrissey"},{"sessionId":"11351","sessionTitle":"Next Generation Sequencing as a Diagnostic Tool for Precision Medicine","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"504622","firstName":"Torsten","lastName":"Haferlach"},{"sessionId":"11354","sessionTitle":"The Role of Genetic Pathways in Bone Marrow Failure","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"562125","firstName":"Steven M.","lastName":"Holland"},{"sessionId":"11355","sessionTitle":"How Long to Anticoagulate My Patient With VTE","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"532477","firstName":"Marc","lastName":"Carrier"},{"sessionId":"11357","sessionTitle":"Immune Thrombocytopenia","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"22321","firstName":"Douglas B.","lastName":"Cines"},{"sessionId":"11358","sessionTitle":"Thrombotic Thrombocytopenic Purpura","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"562615","firstName":"Marie","lastName":"Scully"},{"sessionId":"11359","sessionTitle":"Aplastic Anemia","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"562176","firstName":"Rodrigo T.","lastName":"Calado"},{"sessionId":"11360","sessionTitle":"ALL in Adolescents and Young Adults","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"575290","firstName":"Wendy","lastName":"Stock"},{"sessionId":"11361","sessionTitle":"Individualized Therapy in Patients With AML","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"198350","firstName":"Selina M.","lastName":"Luger"},{"sessionId":"11362","sessionTitle":"Treating and Monitoring Patients With CML","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"561820","firstName":"Francois-Xavier","lastName":"Mahon"},{"sessionId":"11363","sessionTitle":"Novel Therapy Combinations in Multiple Myeloma","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"207904","firstName":"Shaji K.","lastName":"Kumar"},{"sessionId":"11364","sessionTitle":"Relapsed/Refractory Diffuse Large B-Cell Lymphoma","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"575112","firstName":"Laurie H.","lastName":"Sehn"},{"sessionId":"11378","sessionTitle":"Heparin-Induced Thrombocytopenia: HITs and Misses","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"170285","firstName":"Lawrence","lastName":"Rice"},{"sessionId":"11379","sessionTitle":"Tailored Therapy for Patients With Hodgkin Lymphoma","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"260008","firstName":"Stephen M.","lastName":"Ansell"},{"sessionId":"11394","sessionTitle":"Platelet Regulation of Tumor Growth and Metastasis","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"520889","firstName":"Anil","lastName":"Sood"},{"sessionId":"11395","sessionTitle":"Reversal of Anticoagulants","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"501589","firstName":"Mark","lastName":"Crowther"},{"sessionId":"11397","sessionTitle":"Hematopoietic Stem Cell Generation, Reprogramming, and Expansion","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"153294","firstName":"Kateri A.","lastName":"Moore"},{"sessionId":"11399","sessionTitle":"Best of ASH","sessionStartTime":"11:30:00 AM","sessionEndTime":"1:00:00 PM","sessionPerson":"532359","firstName":"Scott A.","lastName":"Armstrong"},{"sessionId":"11399","sessionTitle":"Best of ASH","sessionStartTime":"11:30:00 AM","sessionEndTime":"1:00:00 PM","sessionPerson":"8622","firstName":"Andrew S.","lastName":"Weyrich"},{"sessionId":"11399","sessionTitle":"Best of ASH","sessionStartTime":"11:30:00 AM","sessionEndTime":"1:00:00 PM","sessionPerson":"8622","firstName":"Andrew S.","lastName":"Weyrich"},{"sessionId":"11399","sessionTitle":"Best of ASH","sessionStartTime":"11:30:00 AM","sessionEndTime":"1:00:00 PM","sessionPerson":"532359","firstName":"Scott A.","lastName":"Armstrong"},{"sessionId":"11400","sessionTitle":"Genome Sequencing in the Newborn: Diagnostic Challenges and Emerging Opportunities","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"562727","firstName":"Jennifer","lastName":"Puck"},{"sessionId":"11401","sessionTitle":"Understanding Microbial Immune System Interactions","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"562643","firstName":"Mark","lastName":"Davis"},{"sessionId":"11405","sessionTitle":"Scholarly Work in Quality Improvement","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"525107","firstName":"Vishal","lastName":"Kukreti"},{"sessionId":"11405","sessionTitle":"Scholarly Work in Quality Improvement","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"228952","firstName":"Lisa K.","lastName":"Hicks"},{"sessionId":"11475","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Disordered Erythropoiesis","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"593569","firstName":"Lionel","lastName":"Blanc"},{"sessionId":"11475","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Disordered Erythropoiesis","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"562063","firstName":"John G.","lastName":"Quigley"},{"sessionId":"11476","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Normal Erythropoiesis","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"112529","firstName":"Don M","lastName":"Wojchowski"},{"sessionId":"11476","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Normal Erythropoiesis","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"561891","firstName":"Kathleen M.","lastName":"Sakamoto"},{"sessionId":"11477","sessionTitle":"102. Regulation of Iron Metabolism: Iron homeostasis and related pathophysiology","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"477980","firstName":"Dorine W.","lastName":"Swinkels"},{"sessionId":"11477","sessionTitle":"102. Regulation of Iron Metabolism: Iron homeostasis and related pathophysiology","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"565717","firstName":"Laura","lastName":"Silvestri"},{"sessionId":"11478","sessionTitle":"102. Regulation of Iron Metabolism: Iron and erythropoiesis","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"56480","firstName":"Elizabeta","lastName":"Nemeth"},{"sessionId":"11478","sessionTitle":"102. Regulation of Iron Metabolism: Iron and erythropoiesis","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"42577","firstName":"Sylvia S.","lastName":"Bottomley"},{"sessionId":"11479","sessionTitle":"112. Thalassemia and Globin Gene Regulation I","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"562031","firstName":"Jane A.","lastName":"Little"},{"sessionId":"11479","sessionTitle":"112. Thalassemia and Globin Gene Regulation I","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"560737","firstName":"Swee Lay","lastName":"Thein"},{"sessionId":"11480","sessionTitle":"112. Thalassemia and Globin Gene Regulation II","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"562029","firstName":"Deepa","lastName":"Manwani"},{"sessionId":"11480","sessionTitle":"112. Thalassemia and Globin Gene Regulation II","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"1451","firstName":"Alan R.","lastName":"Cohen"},{"sessionId":"11481","sessionTitle":"113. Hemoglobinopathies, Excluding Thalassemia—Basic and Translational Science: Sickle Cell Disease—Hematopoiesis and Fetal Hemoglobin Augmentation","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"600383","firstName":"Esther A.","lastName":"Obeng"},{"sessionId":"11481","sessionTitle":"113. Hemoglobinopathies, Excluding Thalassemia—Basic and Translational Science: Sickle Cell Disease—Hematopoiesis and Fetal Hemoglobin Augmentation","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"263951","firstName":"Melinda D.","lastName":"Wu"},{"sessionId":"11482","sessionTitle":"113. Hemoglobinopathies, Excluding Thalassemia—Basic and Translational Science: Sickle Cell Disease—Pathophysiology and Investigational Therapies","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"525657","firstName":"Aisha L","lastName":"Walker"},{"sessionId":"11482","sessionTitle":"113. Hemoglobinopathies, Excluding Thalassemia—Basic and Translational Science: Sickle Cell Disease—Pathophysiology and Investigational Therapies","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"238542","firstName":"Wilbur A.","lastName":"Lam"},{"sessionId":"11483","sessionTitle":"114. Hemoglobinopathies, Excluding Thalassemia—Clinical I","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"585711","firstName":"Andrew D.","lastName":"Campbell"},{"sessionId":"11483","sessionTitle":"114. Hemoglobinopathies, Excluding Thalassemia—Clinical I","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"127120","firstName":"Adetola A.","lastName":"Kassim"},{"sessionId":"11484","sessionTitle":"114. Hemoglobinopathies, Excluding Thalassemia—Clinical II","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"498152","firstName":"Allistair","lastName":"Abraham"},{"sessionId":"11484","sessionTitle":"114. Hemoglobinopathies, Excluding Thalassemia—Clinical II","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"533775","firstName":"Courtney D.","lastName":"Fitzhugh"},{"sessionId":"11485","sessionTitle":"114. Hemoglobinopathies, Excluding Thalassemia—Clinical III","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"572066","firstName":"Eugenia Vicky","lastName":"Asare"},{"sessionId":"11485","sessionTitle":"114. Hemoglobinopathies, Excluding Thalassemia—Clinical III","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"566821","firstName":"Najibah Aliyu","lastName":"Galadanci"},{"sessionId":"11486","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: SCN","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"561743","firstName":"Ben A","lastName":"Croker"},{"sessionId":"11486","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: SCN","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"562241","firstName":"Marie-Dominique","lastName":"Filippi, PhD"},{"sessionId":"11487","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages I","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"561656","firstName":"Daniel C.","lastName":"Link"},{"sessionId":"11487","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages I","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"553989","firstName":"Carlo","lastName":"Dufour"},{"sessionId":"11488","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: T cell biology and therapies","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"562100","firstName":"Kavita","lastName":"Dhodapkar"},{"sessionId":"11488","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: T cell biology and therapies","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"94589","firstName":"Kevin D.","lastName":"Bunting"},{"sessionId":"11489","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: B cells and Innate Immunity","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"561804","firstName":"Shannon A.","lastName":"Carty"},{"sessionId":"11489","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: B cells and Innate Immunity","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"562401","firstName":"Victor Youssef","lastName":"Yazbeck"},{"sessionId":"11490","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Platelet Adhesion, Activation, and Biochemistry","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"570382","firstName":"Kellie","lastName":"Machlus"},{"sessionId":"11490","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Platelet Adhesion, Activation, and Biochemistry","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"562169","firstName":"Silvia","lastName":"Giannini"},{"sessionId":"11491","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Vascular Wall Biology and Endothelial Cells","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"4899","firstName":"Alan E.","lastName":"Mast"},{"sessionId":"11491","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Vascular Wall Biology and Endothelial Cells","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"533887","firstName":"Lijun","lastName":"Xia"},{"sessionId":"11492","sessionTitle":"311. Disorders of Platelet Number or Function: ITP: clinical aspects","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"561807","firstName":"Francesco","lastName":"Zaja"},{"sessionId":"11492","sessionTitle":"311. Disorders of Platelet Number or Function: ITP: clinical aspects","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"533871","firstName":"Rachael F.","lastName":"Grace"},{"sessionId":"11493","sessionTitle":"311. Disorders of Platelet Number or Function: ITP: pathophysiologic considerations","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"561917","firstName":"Rick","lastName":"Kapur"},{"sessionId":"11493","sessionTitle":"311. Disorders of Platelet Number or Function: ITP: pathophysiologic considerations","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"575232","firstName":"Jenny M.","lastName":"Despotovic"},{"sessionId":"11494","sessionTitle":"311. Disorders of Platelet Number or Function: Thrombosis in the setting of thrombocytopenia","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"560783","firstName":"Jeffrey","lastName":"Laurence"},{"sessionId":"11494","sessionTitle":"311. Disorders of Platelet Number or Function: Thrombosis in the setting of thrombocytopenia","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"562109","firstName":"Marvin T","lastName":"Nieman"},{"sessionId":"11495","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Factor VIII, Factor X, and Factor V","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"561934","firstName":"Colin","lastName":"Kretz"},{"sessionId":"11495","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Factor VIII, Factor X, and Factor V","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"500678","firstName":"Robert C.","lastName":"Flaumenhaft"},{"sessionId":"11496","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Factor IX, FXII, FXIII, ADAMTS13, TFPI, and vWF","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"562224","firstName":"Maria Cristina","lastName":"Bravo"},{"sessionId":"11496","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Factor IX, FXII, FXIII, ADAMTS13, TFPI, and vWF","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"577026","firstName":"Mettine H.A.","lastName":"Bos"},{"sessionId":"11497","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Preclinical Studies in Bleeding Disorders","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"562373","firstName":"Leslie","lastName":"Padrnos"},{"sessionId":"11497","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Preclinical Studies in Bleeding Disorders","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"574857","firstName":"Brian R.","lastName":"Branchford"},{"sessionId":"11498","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Management of VWD and other Bleeding Disorders","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"501239","firstName":"Donald L","lastName":"Yee"},{"sessionId":"11498","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Management of VWD and other Bleeding Disorders","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"513207","firstName":"Augusto B","lastName":"Federici"},{"sessionId":"11499","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Novel Therapies and Clinical Trials in Bleeding Disorders","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"562108","firstName":"Claire S.","lastName":"Philipp"},{"sessionId":"11499","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Novel Therapies and Clinical Trials in Bleeding Disorders","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"53915","firstName":"James L.","lastName":"Zehnder"},{"sessionId":"11500","sessionTitle":"331. Pathophysiology of Thrombosis I","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"533415","firstName":"Tilman M.","lastName":"Hackeng"},{"sessionId":"11500","sessionTitle":"331. Pathophysiology of Thrombosis I","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"565657","firstName":"Pavan","lastName":"Bendapudi"},{"sessionId":"11501","sessionTitle":"331. Pathophysiology of Thrombosis II","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"481091","firstName":"Sarah E","lastName":"Sartain"},{"sessionId":"11501","sessionTitle":"331. Pathophysiology of Thrombosis II","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"562211","firstName":"Henri M.H.","lastName":"Spronk"},{"sessionId":"11502","sessionTitle":"332. Antithrombotic Therapy: Anticoagulation in Cancer and Beyond","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"587218","firstName":"Lisa M.","lastName":"Baumann Kreuziger"},{"sessionId":"11502","sessionTitle":"332. Antithrombotic Therapy: Anticoagulation in Cancer and Beyond","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"562361","firstName":"Alejandro","lastName":"Lazo-Langner"},{"sessionId":"11503","sessionTitle":"332. Antithrombotic Therapy: Thrombotic Outcomes in Special Populations","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"562816","firstName":"Leonardo R.","lastName":"Brandao"},{"sessionId":"11503","sessionTitle":"332. Antithrombotic Therapy: Thrombotic Outcomes in Special Populations","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"561945","firstName":"Karlyn A.","lastName":"Martin"},{"sessionId":"11504","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Dissecting pathophysiology in transfusion medicine using mouse models","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"63632","firstName":"John","lastName":"Manis"},{"sessionId":"11504","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Dissecting pathophysiology in transfusion medicine using mouse models","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"562008","firstName":"Ross M.","lastName":"Fasano"},{"sessionId":"11505","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Clinical and translational studies in transfusion medicine","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"8447","firstName":"Pampee","lastName":"Young"},{"sessionId":"11505","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Clinical and translational studies in transfusion medicine","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"562047","firstName":"Stella T","lastName":"Chou"},{"sessionId":"11506","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: HSC maintenance and differentiation","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"523139","firstName":"Marieke A. G.","lastName":"Essers"},{"sessionId":"11506","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: HSC maintenance and differentiation","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"562329","firstName":"Dhvanit I","lastName":"Shah"},{"sessionId":"11507","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Extrinsic and intrinsic HSC signaling","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"597643","firstName":"Grant Anthony","lastName":"Challen"},{"sessionId":"11507","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Extrinsic and intrinsic HSC signaling","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"561720","firstName":"Wei","lastName":"Tong"},{"sessionId":"11508","sessionTitle":"502. Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation: Genetics, metabolism, and cell cycle regulation","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"555336","firstName":"Pamela L.","lastName":"Wenzel"},{"sessionId":"11508","sessionTitle":"502. Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation: Genetics, metabolism, and cell cycle regulation","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"198260","firstName":"Keith R.","lastName":"Loeb"},{"sessionId":"11509","sessionTitle":"506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Hematopoietic Microenvironment I","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"562323","firstName":"Stephanie","lastName":"Halene"},{"sessionId":"11509","sessionTitle":"506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Hematopoietic Microenvironment I","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"601171","firstName":"Nina","lastName":"Cabezas-Wallscheid"},{"sessionId":"11510","sessionTitle":"506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Hematopoietic Microenvironment II","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"561870","firstName":"Lev","lastName":"Silberstein"},{"sessionId":"11510","sessionTitle":"506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Hematopoietic Microenvironment II","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"562013","firstName":"Daniel","lastName":"Lucas-Alcaraz"},{"sessionId":"11511","sessionTitle":"508. Bone Marrow Failure: Inherited Bone Marrow Failure: Ribosomopathies and Related Disorders","sessionStartTime":"6:15:00 PM","sessionEndTime":"7:45:00 PM","sessionPerson":"544458","firstName":"John M","lastName":"Gansner"},{"sessionId":"11511","sessionTitle":"508. Bone Marrow Failure: Inherited Bone Marrow Failure: Ribosomopathies and Related Disorders","sessionStartTime":"6:15:00 PM","sessionEndTime":"7:45:00 PM","sessionPerson":"556082","firstName":"Akiko","lastName":"Shimamura"},{"sessionId":"11512","sessionTitle":"508. Bone Marrow Failure: Biology and Therapy","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"562926","firstName":"Amy E.","lastName":"DeZern"},{"sessionId":"11512","sessionTitle":"508. Bone Marrow Failure: Biology and Therapy","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"562284","firstName":"Daria V.","lastName":"Babushok"},{"sessionId":"11513","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Disordered epigenetic regulation in acute myeloid leukemia","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"533534","firstName":"John D.","lastName":"Crispino"},{"sessionId":"11513","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Disordered epigenetic regulation in acute myeloid leukemia","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"534128","firstName":"Ross L.","lastName":"Levine"},{"sessionId":"11514","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Disordered gene expression in myeloid and lymphoid leukemia","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"532496","firstName":"Gang","lastName":"Huang"},{"sessionId":"11514","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Disordered gene expression in myeloid and lymphoid leukemia","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"592809","firstName":"Jay","lastName":"Hess"},{"sessionId":"11515","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Disordered epigenetic regulation in myeloid and lymphoid leukemia","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"562918","firstName":"Omar","lastName":"Abdel-Wahab"},{"sessionId":"11515","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Disordered epigenetic regulation in myeloid and lymphoid leukemia","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"26657","firstName":"Charles G.","lastName":"Mullighan"},{"sessionId":"11516","sessionTitle":"603. Oncogenes and Tumor Suppressors: Nuclear Export and Metabolic Regulation","sessionStartTime":"6:15:00 PM","sessionEndTime":"7:45:00 PM","sessionPerson":"223998","firstName":"Anna M.","lastName":"Eiring"},{"sessionId":"11516","sessionTitle":"603. Oncogenes and Tumor Suppressors: Nuclear Export and Metabolic Regulation","sessionStartTime":"6:15:00 PM","sessionEndTime":"7:45:00 PM","sessionPerson":"500970","firstName":"Michael G.","lastName":"Kharas"},{"sessionId":"11517","sessionTitle":"603. Oncogenes and Tumor Suppressors: Epigenetic and Post-Transcriptional Control","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"593552","firstName":"David B","lastName":"Sykes"},{"sessionId":"11517","sessionTitle":"603. Oncogenes and Tumor Suppressors: Epigenetic and Post-Transcriptional Control","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"533907","firstName":"Nan","lastName":"Zhu"},{"sessionId":"11518","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Novel Therapeutics and Mechanisms of Resistance in Myeloid Disease","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"562196","firstName":"Elie","lastName":"Traer"},{"sessionId":"11518","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Novel Therapeutics and Mechanisms of Resistance in Myeloid Disease","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"562079","firstName":"Sharyn","lastName":"Baker"},{"sessionId":"11519","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Novel Therapeutics and Mechanisms of Resistance in Myeloid Disease","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"562327","firstName":"Tomasz","lastName":"Cierpicki"},{"sessionId":"11519","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Novel Therapeutics and Mechanisms of Resistance in Myeloid Disease","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"250386","firstName":"Andrew A.","lastName":"Lane"},{"sessionId":"11520","sessionTitle":"605. Molecular Pharmacology, Drug Resistance—Lymphoid and Other Diseases: ALL and T-cell malignancies","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"582644","firstName":"Jun J.","lastName":"Yang"},{"sessionId":"11520","sessionTitle":"605. Molecular Pharmacology, Drug Resistance—Lymphoid and Other Diseases: ALL and T-cell malignancies","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"501235","firstName":"Adolfo A.","lastName":"Ferrando"},{"sessionId":"11521","sessionTitle":"605. Molecular Pharmacology, Drug Resistance—Lymphoid and Other Diseases: Chronic Lymphocytic Leukemia and other Lymphoid Diseases","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"500736","firstName":"Tanya","lastName":"Siddiqi"},{"sessionId":"11521","sessionTitle":"605. Molecular Pharmacology, Drug Resistance—Lymphoid and Other Diseases: Chronic Lymphocytic Leukemia and other Lymphoid Diseases","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"561667","firstName":"Matthew S.","lastName":"Davids"},{"sessionId":"11522","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Advances in the Treatment of ALL","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"1750","firstName":"Daniel J.","lastName":"DeAngelo"},{"sessionId":"11522","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Advances in the Treatment of ALL","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"542664","firstName":"Andrea","lastName":"Biondi"},{"sessionId":"11523","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Immune-based therapies and rare subgroups","sessionStartTime":"6:15:00 PM","sessionEndTime":"7:45:00 PM","sessionPerson":"576033","firstName":"Elias J.","lastName":"Jabbour"},{"sessionId":"11523","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Immune-based therapies and rare subgroups","sessionStartTime":"6:15:00 PM","sessionEndTime":"7:45:00 PM","sessionPerson":"562000","firstName":"Maureen M","lastName":"O'Brien"},{"sessionId":"11524","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Advances in Frontline Therapy: Induction, Consolidation, and Maintenance","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"561782","firstName":"Daniel A.","lastName":"Pollyea"},{"sessionId":"11524","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Advances in Frontline Therapy: Induction, Consolidation, and Maintenance","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"562231","firstName":"B Douglas","lastName":"Smith"},{"sessionId":"11525","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Novel Therapies for AML and APL","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"497792","firstName":"Mark G.","lastName":"Frattini"},{"sessionId":"11525","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Novel Therapies for AML and APL","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"587400","firstName":"Justin M","lastName":"Watts"},{"sessionId":"11526","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Risk Factors and Response-Adapted Personalized Medicine","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"567659","firstName":"Marlise R.","lastName":"Luskin"},{"sessionId":"11526","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Risk Factors and Response-Adapted Personalized Medicine","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"562191","firstName":"Jonathan H.","lastName":"Schatz"},{"sessionId":"11527","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: CAR-T Cell Immunotherapy","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"533906","firstName":"Philippe","lastName":"Rousselot"},{"sessionId":"11527","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: CAR-T Cell Immunotherapy","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"546316","firstName":"Andre","lastName":"Baruchel"},{"sessionId":"11528","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Therapy, Excluding CAR-T Cell","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"562478","firstName":"Lewis B.","lastName":"Silverman"},{"sessionId":"11528","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Therapy, Excluding CAR-T Cell","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"544429","firstName":"Farhad","lastName":"Ravandi"},{"sessionId":"11529","sessionTitle":"615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Innovative AML Treatment with Approved Agents","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"533917","firstName":"Francesco","lastName":"Buccisano"},{"sessionId":"11529","sessionTitle":"615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Innovative AML Treatment with Approved Agents","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"529931","firstName":"Tara L.","lastName":"Lin"},{"sessionId":"11530","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Emerging Molecularly-Targeted Therapies in AML","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"561798","firstName":"Mark J.","lastName":"Levis"},{"sessionId":"11530","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Emerging Molecularly-Targeted Therapies in AML","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"538456","firstName":"Amir T.","lastName":"Fathi"},{"sessionId":"11531","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Novel Therapies for Elderly Patients with AML","sessionStartTime":"6:15:00 PM","sessionEndTime":"7:45:00 PM","sessionPerson":"561860","firstName":"Thomas","lastName":"Koehnke"},{"sessionId":"11531","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Novel Therapies for Elderly Patients with AML","sessionStartTime":"6:15:00 PM","sessionEndTime":"7:45:00 PM","sessionPerson":"561867","firstName":"Amer M.","lastName":"Zeidan"},{"sessionId":"11532","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Novel Targeted and Immune-based Approaches in the Treatment of AML","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"561792","firstName":"Monica L.","lastName":"Guzman"},{"sessionId":"11532","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Novel Targeted and Immune-based Approaches in the Treatment of AML","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"563907","firstName":"Courtney D.","lastName":"DiNardo"},{"sessionId":"11533","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Promoting leukemogenesis and risk factors","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"562154","firstName":"Soheil","lastName":"Meshinchi"},{"sessionId":"11533","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Promoting leukemogenesis and risk factors","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"570637","firstName":"Jessica A.","lastName":"Pollard"},{"sessionId":"11534","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Prognostic and predictive markers","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"562156","firstName":"Todd M","lastName":"Cooper"},{"sessionId":"11534","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Prognostic and predictive markers","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"553799","firstName":"Stephane","lastName":"De Botton"},{"sessionId":"11535","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Prognostic information and therapeutic implication","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"596905","firstName":"Mohamad A.","lastName":"Cherry"},{"sessionId":"11535","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Prognostic information and therapeutic implication","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"562119","firstName":"Krzysztof","lastName":"Mrózek"},{"sessionId":"11536","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Therapeutic targeting and clonal evolution in B-ALL","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"584814","firstName":"Claire","lastName":"Schwab"},{"sessionId":"11536","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Therapeutic targeting and clonal evolution in B-ALL","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"533954","firstName":"Sarah K","lastName":"Tasian"},{"sessionId":"11537","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Biology, Signaling Mechanisms, and Response in ALL","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"501235","firstName":"Adolfo A.","lastName":"Ferrando"},{"sessionId":"11537","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Biology, Signaling Mechanisms, and Response in ALL","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"498250","firstName":"Loretta S.","lastName":"Li"},{"sessionId":"11538","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Genetic and Metabolomic Profiling in ALL","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"533644","firstName":"Julie","lastName":"Irving"},{"sessionId":"11538","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Genetic and Metabolomic Profiling in ALL","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"562267","firstName":"H. Phillip","lastName":"Koeffler"},{"sessionId":"11539","sessionTitle":"621. Lymphoma—Genetic/Epigenetic Biology: Genomic characterization of lymphoma and beyond","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"582494","firstName":"David W.","lastName":"Scott"},{"sessionId":"11539","sessionTitle":"621. Lymphoma—Genetic/Epigenetic Biology: Genomic characterization of lymphoma and beyond","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"523342","firstName":"Michael R","lastName":"Green"},{"sessionId":"11540","sessionTitle":"621. Lymphoma—Genetic/Epigenetic Biology: Molecular approaches to describe, monitor, and target lymphoma","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"489206","firstName":"Dan A.","lastName":"Landau"},{"sessionId":"11540","sessionTitle":"621. Lymphoma—Genetic/Epigenetic Biology: Molecular approaches to describe, monitor, and target lymphoma","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"587130","firstName":"Wyndham H.","lastName":"Wilson"},{"sessionId":"11541","sessionTitle":"622. Lymphoma Biology—Non-Genetic Studies: Novel Mechanisms Implicated in Lymphoma Biology","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"561708","firstName":"Christian","lastName":"Steidl"},{"sessionId":"11541","sessionTitle":"622. Lymphoma Biology—Non-Genetic Studies: Novel Mechanisms Implicated in Lymphoma Biology","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"535360","firstName":"Izidore S","lastName":"Lossos"},{"sessionId":"11542","sessionTitle":"622. Lymphoma Biology—Non-Genetic Studies: Prognostic Biomarkers and Immune Mechanisms in Lymphoma","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"562027","firstName":"Kapil N.","lastName":"Bhalla"},{"sessionId":"11542","sessionTitle":"622. Lymphoma Biology—Non-Genetic Studies: Prognostic Biomarkers and Immune Mechanisms in Lymphoma","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"575294","firstName":"Justin","lastName":"Kline"},{"sessionId":"11543","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell Lymphoma—Clinical Studies: Follicular Lymphoma, First Line","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"561929","firstName":"Beth","lastName":"Christian"},{"sessionId":"11543","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell Lymphoma—Clinical Studies: Follicular Lymphoma, First Line","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"270930","firstName":"Loretta","lastName":"Nastoupil"},{"sessionId":"11544","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell Lymphoma—Clinical Studies: Mantle Cell Lymphoma, New Therapies","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"566029","firstName":"Jonathon B","lastName":"Cohen"},{"sessionId":"11544","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell Lymphoma—Clinical Studies: Mantle Cell Lymphoma, New Therapies","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"562072","firstName":"Craig A.","lastName":"Portell"},{"sessionId":"11545","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell Lymphoma—Clinical Studies: Indolent Lymphomas, Novel Therapies, and Diagnostics","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"564847","firstName":"Emanuele","lastName":"Zucca"},{"sessionId":"11545","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell Lymphoma—Clinical Studies: Indolent Lymphomas, Novel Therapies, and Diagnostics","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"534057","firstName":"Harry C.","lastName":"Schouten"},{"sessionId":"11546","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell Lymphoma—Clinical Studies: Hodgkin Lymphoma—Chemotherapy and PET Studies","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"501609","firstName":"Ann S.","lastName":"LaCasce"},{"sessionId":"11546","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell Lymphoma—Clinical Studies: Hodgkin Lymphoma—Chemotherapy and PET Studies","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"572269","firstName":"Catherine S","lastName":"Diefenbach"},{"sessionId":"11547","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell Lymphoma—Clinical Studies: Hodgkin Lymphoma Immunotherapy Studies; nodular lymphocyte predominant Hodgkin lymphoma clinical studies","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"561787","firstName":"Philippe","lastName":"Armand"},{"sessionId":"11547","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell Lymphoma—Clinical Studies: Hodgkin Lymphoma Immunotherapy Studies; nodular lymphocyte predominant Hodgkin lymphoma clinical studies","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"500849","firstName":"Michelle A.","lastName":"Fanale"},{"sessionId":"11548","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell Lymphoma—Clinical Studies: T-Cell Lymphoma Clinical Studies","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"575042","firstName":"Matthew A.","lastName":"Lunning"},{"sessionId":"11548","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell Lymphoma—Clinical Studies: T-Cell Lymphoma Clinical Studies","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"561734","firstName":"Yasuhiro","lastName":"Oki"},{"sessionId":"11549","sessionTitle":"625.  Lymphoma: Pre-Clinical—Chemotherapy and Biologic Agents: Novel targeted therapies for Non-Hodgkin's Lymphomas","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"86689","firstName":"Georg","lastName":"Lenz"},{"sessionId":"11549","sessionTitle":"625.  Lymphoma: Pre-Clinical—Chemotherapy and Biologic Agents: Novel targeted therapies for Non-Hodgkin's Lymphomas","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"182391","firstName":"Matthew J.","lastName":"Barth"},{"sessionId":"11550","sessionTitle":"625. Lymphoma: Pre-Clinical—Chemotherapy and Biologic Agents: New Tools and Emerging Immune-Modulatory Approaches for Non-Hodgkin Lymphomas","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"494601","firstName":"Sascha","lastName":"Dietrich"},{"sessionId":"11550","sessionTitle":"625. Lymphoma: Pre-Clinical—Chemotherapy and Biologic Agents: New Tools and Emerging Immune-Modulatory Approaches for Non-Hodgkin Lymphomas","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"535029","firstName":"Samuel Y.","lastName":"Ng"},{"sessionId":"11551","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Prospective Clinical Trials: Immune-Based Therapeutic Approaches","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"561705","firstName":"Robert A","lastName":"Baiocchi"},{"sessionId":"11551","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Prospective Clinical Trials: Immune-Based Therapeutic Approaches","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"100460","firstName":"Lode J.","lastName":"Swinnen"},{"sessionId":"11552","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Prospective Clinical Trials: Novel Agents and Upfront Approaches","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"595406","firstName":"Philip","lastName":"Imus"},{"sessionId":"11552","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Prospective Clinical Trials: Novel Agents and Upfront Approaches","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"562077","firstName":"Isabelle","lastName":"Fleury"},{"sessionId":"11553","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies: PET-Guided Therapy and Prognostic Models in Diffuse Large B-Cell Lymphoma","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"534485","firstName":"Jakub","lastName":"Svoboda"},{"sessionId":"11553","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies: PET-Guided Therapy and Prognostic Models in Diffuse Large B-Cell Lymphoma","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"562423","firstName":"Nilanjan","lastName":"Ghosh"},{"sessionId":"11554","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies: Molecular Characterization of Diffuse Large B Cell Lymphoma","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"506719","firstName":"Anthony R.","lastName":"Mato"},{"sessionId":"11554","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies: Molecular Characterization of Diffuse Large B Cell Lymphoma","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"596630","firstName":"Allison C.","lastName":"Rosenthal"},{"sessionId":"11555","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies: Predicting Efficacy and Safety of CAR-T cells and Checkpoint Blockade","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"101324","firstName":"Daniel","lastName":"Persky"},{"sessionId":"11555","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies: Predicting Efficacy and Safety of CAR-T cells and Checkpoint Blockade","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"274217","firstName":"Jean L.","lastName":"Koff"},{"sessionId":"11556","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies: Outcomes in Rare Entities: HTLV-1 ATLL, Gray Zone Lymphoma, Primary CNS Lymphoma, and Intravascular DLBCL","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"101324","firstName":"Daniel","lastName":"Persky"},{"sessionId":"11556","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies: Outcomes in Rare Entities: HTLV-1 ATLL, Gray Zone Lymphoma, Primary CNS Lymphoma, and Intravascular DLBCL","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"535364","firstName":"Alison J.","lastName":"Moskowitz"},{"sessionId":"11557","sessionTitle":"631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Novel Targets and CML Stem Cell Biology","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"566175","firstName":"Mhairi","lastName":"Copland"},{"sessionId":"11557","sessionTitle":"631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Novel Targets and CML Stem Cell Biology","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"525661","firstName":"Michael W.","lastName":"Deininger"},{"sessionId":"11558","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Results of Clinical Trials","sessionStartTime":"6:15:00 PM","sessionEndTime":"7:45:00 PM","sessionPerson":"533973","firstName":"Carlo","lastName":"Gambacorti-Passerini"},{"sessionId":"11558","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Results of Clinical Trials","sessionStartTime":"6:15:00 PM","sessionEndTime":"7:45:00 PM","sessionPerson":"528353","firstName":"Thomas","lastName":"Ernst"},{"sessionId":"11559","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: NGS-based and Mechanistic Studies","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"534100","firstName":"Fausto","lastName":"Castagnetti"},{"sessionId":"11559","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: NGS-based and Mechanistic Studies","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"562259","firstName":"Dong-Wook","lastName":"Kim"},{"sessionId":"11560","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Treatment Discontinuation, Dose Reduction, and Prognostic Indicators","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"570648","firstName":"Sarit","lastName":"Assouline"},{"sessionId":"11560","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Treatment Discontinuation, Dose Reduction, and Prognostic Indicators","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"533640","firstName":"Susanne","lastName":"Saussele"},{"sessionId":"11561","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Biologic-Clinical Correlative Studies in MPNs, Including Transplant  ","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"561862","firstName":"Gabriela S.","lastName":"Hobbs"},{"sessionId":"11561","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Biologic-Clinical Correlative Studies in MPNs, Including Transplant  ","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"574747","firstName":"Jason","lastName":"Gotlib"},{"sessionId":"11562","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Phase III and Long-Term Outcome Studies in MPNs","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"562193","firstName":"Brady Lee","lastName":"Stein"},{"sessionId":"11562","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Phase III and Long-Term Outcome Studies in MPNs","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"561818","firstName":"Srdan","lastName":"Verstovsek"},{"sessionId":"11563","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Phase I/II Trials of Novel Agents in MPNs","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"574600","firstName":"Ruben A","lastName":"Mesa"},{"sessionId":"11563","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Phase I/II Trials of Novel Agents in MPNs","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"500711","firstName":"John","lastName":"Mascarenhas"},{"sessionId":"11564","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Identification of novel targets for the treatment of myeloproliferative neoplasms","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"562352","firstName":"Steven W.","lastName":"Lane"},{"sessionId":"11564","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Identification of novel targets for the treatment of myeloproliferative neoplasms","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"562268","firstName":"Ann","lastName":"Mullally"},{"sessionId":"11565","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Molecular events occurring within the myeloproliferative neoplasms","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"562918","firstName":"Omar","lastName":"Abdel-Wahab"},{"sessionId":"11565","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Molecular events occurring within the myeloproliferative neoplasms","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"576103","firstName":"Isabelle","lastName":"Plo"},{"sessionId":"11566","sessionTitle":"636. Myelodysplastic Syndromes—Basic and Translational Studies: Immune and niche dysfunction in MDS","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"565359","firstName":"Ghulam","lastName":"Mufti"},{"sessionId":"11566","sessionTitle":"636. Myelodysplastic Syndromes—Basic and Translational Studies: Immune and niche dysfunction in MDS","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"527724","firstName":"Daniel","lastName":"Starczynowski"},{"sessionId":"11567","sessionTitle":"636. Myelodysplastic Syndromes—Basic and Translational Studies: Molecular Mechanisms of MDS","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"500975","firstName":"Norbert","lastName":"Gattermann"},{"sessionId":"11567","sessionTitle":"636. Myelodysplastic Syndromes—Basic and Translational Studies: Molecular Mechanisms of MDS","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"178093","firstName":"Christopher Y.","lastName":"Park"},{"sessionId":"11568","sessionTitle":"637. Myelodysplastic Syndromes—Clinical Studies: Predicting Drug Response Using Novel Genomic Algorithms","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"574694","firstName":"Mikkael A.","lastName":"Sekeres"},{"sessionId":"11568","sessionTitle":"637. Myelodysplastic Syndromes—Clinical Studies: Predicting Drug Response Using Novel Genomic Algorithms","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"561859","firstName":"Bart L.","lastName":"Scott"},{"sessionId":"11569","sessionTitle":"637. Myelodysplastic Syndromes—Clinical Studies: Inflammation, Immunity, and Iron","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"11014","firstName":"Charlotte M.","lastName":"Niemeyer"},{"sessionId":"11569","sessionTitle":"637. Myelodysplastic Syndromes—Clinical Studies: Inflammation, Immunity, and Iron","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"564096","firstName":"Hetty E.","lastName":"Carraway"},{"sessionId":"11570","sessionTitle":"637. Myelodysplastic Syndromes—Clinical Studies: Genes Inform Genes, Morphology, and Clinical Outcomes","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"561803","firstName":"Eric","lastName":"Solary"},{"sessionId":"11570","sessionTitle":"637. Myelodysplastic Syndromes—Clinical Studies: Genes Inform Genes, Morphology, and Clinical Outcomes","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"575934","firstName":"Charles A.","lastName":"Schiffer"},{"sessionId":"11571","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Therapeutic Resistance in CLL","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"530568","firstName":"Adrian","lastName":"Wiestner"},{"sessionId":"11571","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Therapeutic Resistance in CLL","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"561962","firstName":"Sami N.","lastName":"Malek"},{"sessionId":"11572","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: CLL in Its Microenvironment","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"572234","firstName":"Stephen","lastName":"Devereux"},{"sessionId":"11572","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: CLL in Its Microenvironment","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"574787","firstName":"Clare","lastName":"Sun"},{"sessionId":"11573","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Epigenetics, Evolution, and the B Cell Receptor","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"480342","firstName":"Jennifer R.","lastName":"Brown"},{"sessionId":"11573","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Epigenetics, Evolution, and the B Cell Receptor","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"577487","firstName":"Christopher C.","lastName":"Oakes"},{"sessionId":"11574","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Targeting MRD Negative CLL Through Combinations of Novel Agents and Antibody ","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"535368","firstName":"Jose F.","lastName":"Leis"},{"sessionId":"11574","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Targeting MRD Negative CLL Through Combinations of Novel Agents and Antibody ","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"565947","firstName":"Ian W.","lastName":"Flinn"},{"sessionId":"11575","sessionTitle":"642. CLL: Therapy, excluding Transplantation: New Agents, Infections, and PET/CT","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"562034","firstName":"Alexey","lastName":"Danilov"},{"sessionId":"11575","sessionTitle":"642. CLL: Therapy, excluding Transplantation: New Agents, Infections, and PET/CT","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"534331","firstName":"Jacqueline C.","lastName":"Barrientos"},{"sessionId":"11576","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Targeting MRD Negative CLL with Combinations of Novel Agents and Chemoimmunotherapy Regimens, New Treatments","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"533412","firstName":"Sameer A.","lastName":"Parikh"},{"sessionId":"11576","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Targeting MRD Negative CLL with Combinations of Novel Agents and Chemoimmunotherapy Regimens, New Treatments","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"561667","firstName":"Matthew S.","lastName":"Davids"},{"sessionId":"11577","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: New Insights into the Role of the Immune Microenvironment of Multiple Myeloma","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"575817","firstName":"Qing","lastName":"Yi"},{"sessionId":"11577","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: New Insights into the Role of the Immune Microenvironment of Multiple Myeloma","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"49382","firstName":"Karin","lastName":"Vanderkerken"},{"sessionId":"11578","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Transcriptional Regulatory Circuitries of Multiple Myeloma","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"20155","firstName":"Catherine","lastName":"Pellat-Deceunynck"},{"sessionId":"11578","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Transcriptional Regulatory Circuitries of Multiple Myeloma","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"561881","firstName":"P. Leif","lastName":"Bergsagel"},{"sessionId":"11579","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Genomics of The Pathogenesis and Progression of Multiple Myeloma","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"533682","firstName":"Paola","lastName":"Neri"},{"sessionId":"11579","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Genomics of The Pathogenesis and Progression of Multiple Myeloma","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"575949","firstName":"Dirk","lastName":"Hose"},{"sessionId":"11580","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Novel Immunotherapeutic Strategies in Multiple Myeloma","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"601123","firstName":"Marc S","lastName":"Raab"},{"sessionId":"11580","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Novel Immunotherapeutic Strategies in Multiple Myeloma","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"562246","firstName":"Charlotte","lastName":"Pawlyn"},{"sessionId":"11581","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Emerging New Targets and Mechanisms of Resistance","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"561741","firstName":"Nicola","lastName":"Lehners"},{"sessionId":"11581","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Emerging New Targets and Mechanisms of Resistance","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"501405","firstName":"Lawrence H.","lastName":"Boise"},{"sessionId":"11582","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Immunotherapy in Myeloma and Amyloid","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"24610","firstName":"Dan T.","lastName":"Vogl"},{"sessionId":"11582","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Immunotherapy in Myeloma and Amyloid","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"510498","firstName":"Yvonne A","lastName":"Efebera"},{"sessionId":"11583","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Studies in Relapsed and Refractory Multiple Myeloma","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"571577","firstName":"Saad Z","lastName":"Usmani"},{"sessionId":"11583","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Studies in Relapsed and Refractory Multiple Myeloma","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"561723","firstName":"Rachid","lastName":"Baz"},{"sessionId":"11584","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Upfront Therapy for Multiple Myeloma: Induction and Maintenance","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"562943","firstName":"Nina","lastName":"Shah"},{"sessionId":"11584","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Upfront Therapy for Multiple Myeloma: Induction and Maintenance","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"561674","firstName":"Hans C.","lastName":"Lee"},{"sessionId":"11585","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: T cell regeneration and donor graft effects on HCT","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"546370","firstName":"Melody","lastName":"Smith"},{"sessionId":"11585","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: T cell regeneration and donor graft effects on HCT","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"562157","firstName":"Jonathan","lastName":"Hoggatt"},{"sessionId":"11586","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Novel T cell targets in regulation of GVHD and GVL","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"601279","firstName":"Ivan","lastName":"Maillard"},{"sessionId":"11586","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Novel T cell targets in regulation of GVHD and GVL","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"561668","firstName":"Yi","lastName":"Zhang"},{"sessionId":"11587","sessionTitle":"703. Adoptive Immunotherapy: Gene Engineered T cells for Hematologic Malignancies","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"126136","firstName":"Claudia","lastName":"Rossig"},{"sessionId":"11587","sessionTitle":"703. Adoptive Immunotherapy: Gene Engineered T cells for Hematologic Malignancies","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"574534","firstName":"Marco L.","lastName":"Davila"},{"sessionId":"11588","sessionTitle":"703. Adoptive Immunotherapy: Immune Therapeutics for Hematologic Cancers: Artificial Receptors and Beyond","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"562086","firstName":"Kirsten M.","lastName":"Williams"},{"sessionId":"11588","sessionTitle":"703. Adoptive Immunotherapy: Immune Therapeutics for Hematologic Cancers: Artificial Receptors and Beyond","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"533954","firstName":"Sarah K","lastName":"Tasian"},{"sessionId":"11589","sessionTitle":"711. Cell Collection and Processing: Optimization of Hematopoietic Graft Using Small Molecules in Culture","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"501286","firstName":"Lawrence S.","lastName":"Lamb Jr."},{"sessionId":"11589","sessionTitle":"711. Cell Collection and Processing: Optimization of Hematopoietic Graft Using Small Molecules in Culture","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"562067","firstName":"Nadim","lastName":"Mahmud"},{"sessionId":"11590","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Alternative Donor Transplants","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"535376","firstName":"Partow","lastName":"Kebriaei"},{"sessionId":"11590","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Alternative Donor Transplants","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"539765","firstName":"Rizwan","lastName":"Romee"},{"sessionId":"11591","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Preparative Regimens ","sessionStartTime":"6:15:00 PM","sessionEndTime":"7:45:00 PM","sessionPerson":"561692","firstName":"Betul","lastName":"Oran"},{"sessionId":"11591","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Preparative Regimens ","sessionStartTime":"6:15:00 PM","sessionEndTime":"7:45:00 PM","sessionPerson":"518724","firstName":"Angela R.","lastName":"Smith"},{"sessionId":"11592","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Microbiota, CMV, and GVHD","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"562227","firstName":"Boglarka","lastName":"Gyurkocza"},{"sessionId":"11592","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Microbiota, CMV, and GVHD","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"533633","firstName":"Filippo","lastName":"Milano"},{"sessionId":"11593","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Prevention","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"506760","firstName":"Francesca","lastName":"Bonifazi"},{"sessionId":"11593","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Prevention","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"3306","firstName":"Mitchell E.","lastName":"Horwitz"},{"sessionId":"11594","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Treatment","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"562392","firstName":"Monica","lastName":"Thakar"},{"sessionId":"11594","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Treatment","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"503964","firstName":"Annalisa","lastName":"Ruggeri"},{"sessionId":"11595","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Pathobiology","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"562392","firstName":"Monica","lastName":"Thakar"},{"sessionId":"11595","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Pathobiology","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"505757","firstName":"David","lastName":"Ritchie"},{"sessionId":"11596","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: New strategies in diagnosis and therapy of malignancy relapse  ","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"212370","firstName":"William A.","lastName":"Wood"},{"sessionId":"11596","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: New strategies in diagnosis and therapy of malignancy relapse  ","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"561890","firstName":"Smita","lastName":"Bhatia"},{"sessionId":"11597","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Progress in survivorship care of transplant patients ","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"562086","firstName":"Kirsten M.","lastName":"Williams"},{"sessionId":"11597","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Progress in survivorship care of transplant patients ","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"529286","firstName":"Shahrukh K.","lastName":"Hashmi"},{"sessionId":"11598","sessionTitle":"731. Clinical Autologous Transplantation: Results: Novel Conditioning & Maintenance Approaches","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"562145","firstName":"Muzaffar H.","lastName":"Qazilbash"},{"sessionId":"11598","sessionTitle":"731. Clinical Autologous Transplantation: Results: Novel Conditioning & Maintenance Approaches","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"561755","firstName":"Parameswaran","lastName":"Hari"},{"sessionId":"11599","sessionTitle":"731. Clinical Autologous Transplantation: Results: Modern Indications & Post-Transplant Check Point Inhibitors in Lymphoma and Myeloma","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"508312","firstName":"Mehdi","lastName":"Hamadani"},{"sessionId":"11599","sessionTitle":"731. Clinical Autologous Transplantation: Results: Modern Indications & Post-Transplant Check Point Inhibitors in Lymphoma and Myeloma","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"561911","firstName":"Peter A","lastName":"Riedell"},{"sessionId":"11600","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Donor Selection in the Haplo Transplant Era","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"42253","firstName":"Veronika","lastName":"Bachanova"},{"sessionId":"11600","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Donor Selection in the Haplo Transplant Era","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"585091","firstName":"Richard J.","lastName":"Jones"},{"sessionId":"11601","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Outcomes in Myeloid Leukemia and Impact of Conditioning","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"515061","firstName":"Takanori","lastName":"Teshima"},{"sessionId":"11601","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Outcomes in Myeloid Leukemia and Impact of Conditioning","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"568864","firstName":"Peter","lastName":"Dreger"},{"sessionId":"11602","sessionTitle":"801. Gene Therapy and Transfer: Immune Disorders, CAR-T Cells, and B-hemoglobinopathies","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"561839","firstName":"Shannon L","lastName":"Maude"},{"sessionId":"11602","sessionTitle":"801. Gene Therapy and Transfer: Immune Disorders, CAR-T Cells, and B-hemoglobinopathies","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"532718","firstName":"Jennifer L","lastName":"Gori"},{"sessionId":"11603","sessionTitle":"801. Gene Therapy and Transfer: Gene Therapy for Hemophilia and Improving Lentiviral Vectors","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"552335","firstName":"Mitchell J.","lastName":"Weiss"},{"sessionId":"11603","sessionTitle":"801. Gene Therapy and Transfer: Gene Therapy for Hemophilia and Improving Lentiviral Vectors","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"561931","firstName":"Jennifer","lastName":"Adair"},{"sessionId":"11604","sessionTitle":"802. Chemical Biology and Experimental Therapeutics:  Functional Approaches for Diagnostics, Biomarker Development, and Discovery of New Targeting Strategies","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"561662","firstName":"Caroline A","lastName":"Heckman"},{"sessionId":"11604","sessionTitle":"802. Chemical Biology and Experimental Therapeutics:  Functional Approaches for Diagnostics, Biomarker Development, and Discovery of New Targeting Strategies","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"562330","firstName":"Jolanta","lastName":"Grembecka"},{"sessionId":"11605","sessionTitle":"901. Health Services Research—Non-Malignant Conditions: Consultative Hematology","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"562416","firstName":"Kim","lastName":"Smith-Whitley"},{"sessionId":"11605","sessionTitle":"901. Health Services Research—Non-Malignant Conditions: Consultative Hematology","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"561970","firstName":"Prakash","lastName":"Vishnu"},{"sessionId":"11606","sessionTitle":"901. Health Services Research—Non-Malignant Conditions: Sickle Cell Disease","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"562181","firstName":"Suzy","lastName":"Bendellali"},{"sessionId":"11606","sessionTitle":"901. Health Services Research—Non-Malignant Conditions: Sickle Cell Disease","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"576859","firstName":"Charles T.","lastName":"Quinn"},{"sessionId":"11607","sessionTitle":"901. Health Services Research—Non-Malignant Conditions: Thrombosis","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"325","firstName":"Donald M","lastName":"Arnold"},{"sessionId":"11607","sessionTitle":"901. Health Services Research—Non-Malignant Conditions: Thrombosis","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"534630","firstName":"Nathan T.","lastName":"Connell"},{"sessionId":"11608","sessionTitle":"902. Health Services Research—Malignant Diseases: Pediatric and AYA Outcomes","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"556662","firstName":"Navneet S.","lastName":"Majhail"},{"sessionId":"11608","sessionTitle":"902. Health Services Research—Malignant Diseases: Pediatric and AYA Outcomes","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"562353","firstName":"Kira","lastName":"Bona"},{"sessionId":"11609","sessionTitle":"902. Health Services Research—Malignant Diseases: Race-Ethnic and Age-Related Disparities","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"212370","firstName":"William A.","lastName":"Wood"},{"sessionId":"11609","sessionTitle":"902. Health Services Research—Malignant Diseases: Race-Ethnic and Age-Related Disparities","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"562421","firstName":"Scott","lastName":"Huntington"},{"sessionId":"11610","sessionTitle":"902. Health Services Research—Malignant Diseases: Adult Outcomes","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"563648","firstName":"Emily Riehm","lastName":"Meier"},{"sessionId":"11610","sessionTitle":"902. Health Services Research—Malignant Diseases: Adult Outcomes","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"601148","firstName":"Andrew M.","lastName":"Brunner"},{"sessionId":"11611","sessionTitle":"902. Health Services Research—Malignant Diseases: Innovative Predictors and Outcomes","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"499505","firstName":"Charles L.","lastName":"Bennett"},{"sessionId":"11611","sessionTitle":"902. Health Services Research—Malignant Diseases: Innovative Predictors and Outcomes","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"566239","firstName":"Taiga","lastName":"Nishihori"},{"sessionId":"11612","sessionTitle":"903. Outcomes Research—Non-Malignant Conditions: Sickle Cell Disease","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"500745","firstName":"Amanda M.","lastName":"Brandow"},{"sessionId":"11612","sessionTitle":"903. Outcomes Research—Non-Malignant Conditions: Sickle Cell Disease","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"562395","firstName":"Jeffrey","lastName":"Lebensburger"},{"sessionId":"11613","sessionTitle":"903. Outcomes Research—Non-Malignant Conditions: Health Impact and Mortality","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"601141","firstName":"Neil","lastName":"Zaki"},{"sessionId":"11613","sessionTitle":"903. Outcomes Research—Non-Malignant Conditions: Health Impact and Mortality","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"562461","firstName":"Bethany T","lastName":"Samuelson Bannow"},{"sessionId":"11614","sessionTitle":"904. Outcomes Research—Malignant Conditions: Impacting Healthcare Utilization and End of Life Care","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"247597","firstName":"Oreofe O.","lastName":"Odejide"},{"sessionId":"11614","sessionTitle":"904. Outcomes Research—Malignant Conditions: Impacting Healthcare Utilization and End of Life Care","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"533521","firstName":"Alok A.","lastName":"Khorana"},{"sessionId":"11615","sessionTitle":"904. Outcomes Research—Malignant Conditions: Survivorship and Quality of Life in Lymphoid Malignancies","sessionStartTime":"6:15:00 PM","sessionEndTime":"7:45:00 PM","sessionPerson":"511976","firstName":"Deepa","lastName":"Jagadeesh"},{"sessionId":"11615","sessionTitle":"904. Outcomes Research—Malignant Conditions: Survivorship and Quality of Life in Lymphoid Malignancies","sessionStartTime":"6:15:00 PM","sessionEndTime":"7:45:00 PM","sessionPerson":"562337","firstName":"Todd","lastName":"Gibson"},{"sessionId":"11616","sessionTitle":"904. Outcomes Research—Malignant Conditions: Impact of Disease Burden in Myeloma and Other Hematologic Malignancies","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"596383","firstName":"Tara O.","lastName":"Henderson"},{"sessionId":"11616","sessionTitle":"904. Outcomes Research—Malignant Conditions: Impact of Disease Burden in Myeloma and Other Hematologic Malignancies","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"508146","firstName":"Marcie L.","lastName":"Riches"},{"sessionId":"11617","sessionTitle":"904. Outcomes Research—Malignant Conditions: Quality Of Life and Outcomes in Myelodysplastic Syndromes and Leukemias","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"228952","firstName":"Lisa K.","lastName":"Hicks"},{"sessionId":"11617","sessionTitle":"904. Outcomes Research—Malignant Conditions: Quality Of Life and Outcomes in Myelodysplastic Syndromes and Leukemias","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"568115","firstName":"Catherine C.","lastName":"Coombs"},{"sessionId":"11618","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis I","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"562203","firstName":"Claudia D.","lastName":"Baldus"},{"sessionId":"11618","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis I","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"562216","firstName":"Lars","lastName":"Bullinger"},{"sessionId":"11619","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis II","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"562020","firstName":"Katherine","lastName":"Tarlock"},{"sessionId":"11619","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis II","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"562289","firstName":"Vikram R","lastName":"Paralkar"},{"sessionId":"11620","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis III","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"569454","firstName":"Aaron D","lastName":"Goldberg"},{"sessionId":"11620","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis III","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"562102","firstName":"Francine E.","lastName":"Garrett-Bakelman"},{"sessionId":"11622","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Mechanisms of Resistance and Prognosis ","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"562151","firstName":"Helena","lastName":"Jernberg-Wiklund"},{"sessionId":"11622","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Mechanisms of Resistance and Prognosis ","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"575949","firstName":"Dirk","lastName":"Hose"},{"sessionId":"11623","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Genomics ","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"562039","firstName":"Salomon","lastName":"Manier"},{"sessionId":"11623","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Genomics ","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"562248","firstName":"Brian A","lastName":"Walker"},{"sessionId":"11625","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation II","sessionStartTime":"6:15:00 PM","sessionEndTime":"7:45:00 PM","sessionPerson":"599254","firstName":"Kenneth H","lastName":"Shain"},{"sessionId":"11625","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation II","sessionStartTime":"6:15:00 PM","sessionEndTime":"7:45:00 PM","sessionPerson":"564289","firstName":"Elisabet E.","lastName":"Manasanch"},{"sessionId":"11626","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation I","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"561830","firstName":"Vania T M","lastName":"Hungria"},{"sessionId":"11626","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation I","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"561763","firstName":"Jesus G.","lastName":"Berdeja"},{"sessionId":"11627","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Transplant Outcomes","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"562403","firstName":"David A.","lastName":"Jacobsohn"},{"sessionId":"11627","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Transplant Outcomes","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"562404","firstName":"Muna","lastName":"Qayed"},{"sessionId":"11628","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: GVH and GVL","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"562451","firstName":"Aleksandr","lastName":"Lazaryan"},{"sessionId":"11628","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: GVH and GVL","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"509335","firstName":"Friedrich","lastName":"Stoelzel"},{"sessionId":"11718","sessionTitle":"Identification of Germline Syndromes ","sessionStartTime":"1:15:00 PM","sessionEndTime":"2:00:00 PM","sessionPerson":"582644","firstName":"Jun J.","lastName":"Yang"},{"sessionId":"11718","sessionTitle":"Identification of Germline Syndromes ","sessionStartTime":"1:15:00 PM","sessionEndTime":"2:00:00 PM","sessionPerson":"590892","firstName":"Alison A.","lastName":"Bertuch"},{"sessionId":"11719","sessionTitle":"Novel Aspects of Known Predisposition Syndrome","sessionStartTime":"2:00:00 PM","sessionEndTime":"2:45:00 PM","sessionPerson":"521892","firstName":"Hamish S","lastName":"Scott"},{"sessionId":"11719","sessionTitle":"Novel Aspects of Known Predisposition Syndrome","sessionStartTime":"2:00:00 PM","sessionEndTime":"2:45:00 PM","sessionPerson":"575330","firstName":"Marcin W.","lastName":"Wlodarski"},{"sessionId":"11720","sessionTitle":"Emerging New Syndromes","sessionStartTime":"2:45:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"601138","firstName":"Mary Y.","lastName":"Armanios"},{"sessionId":"11720","sessionTitle":"Emerging New Syndromes","sessionStartTime":"2:45:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"601139","firstName":"Prapti A.","lastName":"Patel"},{"sessionId":"11721","sessionTitle":"Effects of Combinations of Germline Variants Including Penetrance/Molecular Progression","sessionStartTime":"3:45:00 PM","sessionEndTime":"4:30:00 PM","sessionPerson":"580316","firstName":"Elizabeth A.","lastName":"Griffiths"},{"sessionId":"11721","sessionTitle":"Effects of Combinations of Germline Variants Including Penetrance/Molecular Progression","sessionStartTime":"3:45:00 PM","sessionEndTime":"4:30:00 PM","sessionPerson":"601140","firstName":"Carolyn Jane","lastName":"Owen"},{"sessionId":"11722","sessionTitle":"Reporting of Families and Variant Interpretation","sessionStartTime":"4:30:00 PM","sessionEndTime":"5:15:00 PM","sessionPerson":"589132","firstName":"Michael Francis","lastName":"Walsh"},{"sessionId":"11722","sessionTitle":"Reporting of Families and Variant Interpretation","sessionStartTime":"4:30:00 PM","sessionEndTime":"5:15:00 PM","sessionPerson":"534556","firstName":"Marshall","lastName":"Horwitz"},{"sessionId":"11723","sessionTitle":"Point-Counter Point: Prophylactic Transplantation for Leukemia Predisposition Syndromes","sessionStartTime":"5:15:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"598650","firstName":"Christopher C.","lastName":"Porter"},{"sessionId":"11723","sessionTitle":"Point-Counter Point: Prophylactic Transplantation for Leukemia Predisposition Syndromes","sessionStartTime":"5:15:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"601143","firstName":"Luke","lastName":"Maese"},{"sessionId":"11723","sessionTitle":"Point-Counter Point: Prophylactic Transplantation for Leukemia Predisposition Syndromes","sessionStartTime":"5:15:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"601300","firstName":"Kayla","lastName":"Hamilton"},{"sessionId":"11723","sessionTitle":"Point-Counter Point: Prophylactic Transplantation for Leukemia Predisposition Syndromes","sessionStartTime":"5:15:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"601143","firstName":"Luke","lastName":"Maese"},{"sessionId":"11723","sessionTitle":"Point-Counter Point: Prophylactic Transplantation for Leukemia Predisposition Syndromes","sessionStartTime":"5:15:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"562425","firstName":"Michael A","lastName":"Pulsipher"},{"sessionId":"11723","sessionTitle":"Point-Counter Point: Prophylactic Transplantation for Leukemia Predisposition Syndromes","sessionStartTime":"5:15:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"601301","firstName":"Jonathan M.","lastName":"Marron"},{"sessionId":"11727","sessionTitle":"ASH-FDA Joint Symposium on New Drugs in Acute Myeloid Leukemia","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"574897","firstName":"Richard","lastName":"Pazdur"},{"sessionId":"11729","sessionTitle":"ASH-FDA Joint Symposium on New Drug Approvals in Acute Lymphoid Leukemia and Non-Hodgkin Lymphoma","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"574897","firstName":"Richard","lastName":"Pazdur"},{"sessionId":"11731","sessionTitle":"Stem Cells ","sessionStartTime":"1:05:00 PM","sessionEndTime":"1:50:00 PM","sessionPerson":"589704","firstName":"Patricia","lastName":"Ernst"},{"sessionId":"11732","sessionTitle":"Signaling and Developmental Hematopoiesis ","sessionStartTime":"1:50:00 PM","sessionEndTime":"2:35:00 PM","sessionPerson":"601155","firstName":"David","lastName":"Traver"},{"sessionId":"11732","sessionTitle":"Signaling and Developmental Hematopoiesis ","sessionStartTime":"1:50:00 PM","sessionEndTime":"2:35:00 PM","sessionPerson":"601284","firstName":"Claudia","lastName":"Lengerke"},{"sessionId":"11733","sessionTitle":"Myeloid Malignancies","sessionStartTime":"5:00:00 PM","sessionEndTime":"5:45:00 PM","sessionPerson":"534434","firstName":"Benjamin L.","lastName":"Ebert"},{"sessionId":"11734","sessionTitle":"Transcription Factors/Epigenetics","sessionStartTime":"4:15:00 PM","sessionEndTime":"5:00:00 PM","sessionPerson":"575194","firstName":"Ulrich G.","lastName":"Steidl"},{"sessionId":"11735","sessionTitle":"New Investigators ","sessionStartTime":"2:35:00 PM","sessionEndTime":"3:25:00 PM","sessionPerson":"562807","firstName":"Nancy E.","lastName":"Speck"},{"sessionId":"11737","sessionTitle":"Stem Cells and Aging ","sessionStartTime":"1:05:00 PM","sessionEndTime":"2:05:00 PM","sessionPerson":"562753","firstName":"Ashley E","lastName":"Rosko"},{"sessionId":"11738","sessionTitle":"Aging, Inflammation and Immune Function ","sessionStartTime":"2:20:00 PM","sessionEndTime":"3:05:00 PM","sessionPerson":"575285","firstName":"Andrew","lastName":"Artz"},{"sessionId":"11740","sessionTitle":"Thrombosis and Aging","sessionStartTime":"3:35:00 PM","sessionEndTime":"4:20:00 PM","sessionPerson":"582147","firstName":"Matthew T.","lastName":"Rondina"},{"sessionId":"11741","sessionTitle":"Clinical and Biologic Correlates of Frailty in Hematology","sessionStartTime":"4:35:00 PM","sessionEndTime":"5:20:00 PM","sessionPerson":"595803","firstName":"Heidi","lastName":"Klepin"},{"sessionId":"11747","sessionTitle":"K2R Introductory Panel","sessionStartTime":"2:00:00 PM","sessionEndTime":"2:30:00 PM","sessionPerson":"53371","firstName":"Martha P.","lastName":"Mims"},{"sessionId":"11752","sessionTitle":"Plenary Scientific Session","sessionStartTime":"2:00:00 PM","sessionEndTime":"4:00:00 PM","sessionPerson":"562033","firstName":"Janis L.","lastName":"Abkowitz"},{"sessionId":"11752","sessionTitle":"Plenary Scientific Session","sessionStartTime":"2:00:00 PM","sessionEndTime":"4:00:00 PM","sessionPerson":"562918","firstName":"Omar","lastName":"Abdel-Wahab"},{"sessionId":"11752","sessionTitle":"Plenary Scientific Session","sessionStartTime":"2:00:00 PM","sessionEndTime":"4:00:00 PM","sessionPerson":"569684","firstName":"Neil","lastName":"Shah"},{"sessionId":"11752","sessionTitle":"Plenary Scientific Session","sessionStartTime":"2:00:00 PM","sessionEndTime":"4:00:00 PM","sessionPerson":"601258","firstName":"Naomi L.C.","lastName":"Luban"},{"sessionId":"11752","sessionTitle":"Plenary Scientific Session","sessionStartTime":"2:00:00 PM","sessionEndTime":"4:00:00 PM","sessionPerson":"534647","firstName":"Jorge","lastName":"Di Paola"},{"sessionId":"11752","sessionTitle":"Plenary Scientific Session","sessionStartTime":"2:00:00 PM","sessionEndTime":"4:00:00 PM","sessionPerson":"601259","firstName":"George P.","lastName":"Canellos"},{"sessionId":"11902","sessionTitle":"Opening Remarks","sessionStartTime":"1:00:00 PM","sessionEndTime":"1:05:00 PM","sessionPerson":"585622","firstName":"Rebecca L.","lastName":"Olin"},{"sessionId":"11902","sessionTitle":"Opening Remarks","sessionStartTime":"1:00:00 PM","sessionEndTime":"1:05:00 PM","sessionPerson":"562752","firstName":"Tanya M.","lastName":"Wildes"},{"sessionId":"11903","sessionTitle":"Opening Remarks","sessionStartTime":"1:00:00 PM","sessionEndTime":"1:05:00 PM","sessionPerson":"553091","firstName":"Sant-Rayn","lastName":"Pasricha"},{"sessionId":"11903","sessionTitle":"Opening Remarks","sessionStartTime":"1:00:00 PM","sessionEndTime":"1:05:00 PM","sessionPerson":"477980","firstName":"Dorine W.","lastName":"Swinkels"},{"sessionId":"11906","sessionTitle":"Opening Remarks ","sessionStartTime":"1:00:00 PM","sessionEndTime":"1:15:00 PM","sessionPerson":"573906","firstName":"Lucy","lastName":"Godley"},{"sessionId":"11910","sessionTitle":"Opening Remarks","sessionStartTime":"1:00:00 PM","sessionEndTime":"1:05:00 PM","sessionPerson":"570138","firstName":"Leonard","lastName":"Zon"},{"sessionId":"11910","sessionTitle":"Opening Remarks","sessionStartTime":"1:00:00 PM","sessionEndTime":"1:05:00 PM","sessionPerson":"534128","firstName":"Ross L.","lastName":"Levine"},{"sessionId":"11911","sessionTitle":"Opening Remarks ","sessionStartTime":"1:00:00 PM","sessionEndTime":"1:05:00 PM","sessionPerson":"565946","firstName":"Stephen M","lastName":"Ansell"},{"sessionId":"11911","sessionTitle":"Opening Remarks ","sessionStartTime":"1:00:00 PM","sessionEndTime":"1:05:00 PM","sessionPerson":"573876","firstName":"Ronald","lastName":"Levy"},{"sessionId":"11942","sessionTitle":"Featured Topic: Hemophilia Revolution","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"508870","firstName":"Barbara","lastName":"Konkle"},{"sessionId":"11942","sessionTitle":"Featured Topic: Hemophilia Revolution","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"559648","firstName":"David","lastName":"Lillicrap"},{"sessionId":"11943","sessionTitle":"Featured Topic: Combination Therapies: How Are We Deciding What to Utilize?","sessionStartTime":"1:15:00 PM","sessionEndTime":"2:15:00 PM","sessionPerson":"587668","firstName":"Steven","lastName":"Grant"},{"sessionId":"11943","sessionTitle":"Featured Topic: Combination Therapies: How Are We Deciding What to Utilize?","sessionStartTime":"1:15:00 PM","sessionEndTime":"2:15:00 PM","sessionPerson":"601260","firstName":"Donna","lastName":"Przepiorka"},{"sessionId":"12020","sessionTitle":"Panel Discussion/Questions","sessionStartTime":"2:05:00 PM","sessionEndTime":"2:20:00 PM","sessionPerson":"601191","firstName":"Michael Gustave","lastName":"Poulos"},{"sessionId":"12020","sessionTitle":"Panel Discussion/Questions","sessionStartTime":"2:05:00 PM","sessionEndTime":"2:20:00 PM","sessionPerson":"601193","firstName":"Gerald","lastName":"De Haan"},{"sessionId":"12020","sessionTitle":"Panel Discussion/Questions","sessionStartTime":"2:05:00 PM","sessionEndTime":"2:20:00 PM","sessionPerson":"587770","firstName":"Laura M.","lastName":"Calvi"},{"sessionId":"12020","sessionTitle":"Panel Discussion/Questions","sessionStartTime":"2:05:00 PM","sessionEndTime":"2:20:00 PM","sessionPerson":"570420","firstName":"Cynthia E","lastName":"Dunbar"},{"sessionId":"12021","sessionTitle":"Panel Discussion/Questions","sessionStartTime":"3:05:00 PM","sessionEndTime":"3:20:00 PM","sessionPerson":"601194","firstName":"Hartmut","lastName":"Geiger"},{"sessionId":"12021","sessionTitle":"Panel Discussion/Questions","sessionStartTime":"3:05:00 PM","sessionEndTime":"3:20:00 PM","sessionPerson":"601195","firstName":"Fabienne","lastName":"Lucas"},{"sessionId":"12021","sessionTitle":"Panel Discussion/Questions","sessionStartTime":"3:05:00 PM","sessionEndTime":"3:20:00 PM","sessionPerson":"585045","firstName":"Bindu","lastName":"Kanapuru"},{"sessionId":"12022","sessionTitle":"Panel Discussion/Questions","sessionStartTime":"4:20:00 PM","sessionEndTime":"4:35:00 PM","sessionPerson":"582147","firstName":"Matthew T.","lastName":"Rondina"},{"sessionId":"12022","sessionTitle":"Panel Discussion/Questions","sessionStartTime":"4:20:00 PM","sessionEndTime":"4:35:00 PM","sessionPerson":"599642","firstName":"Alisa S","lastName":"Wolberg"},{"sessionId":"12022","sessionTitle":"Panel Discussion/Questions","sessionStartTime":"4:20:00 PM","sessionEndTime":"4:35:00 PM","sessionPerson":"587993","firstName":"Pavel","lastName":"Davizon-Castillo"},{"sessionId":"12023","sessionTitle":"Closing Remarks ","sessionStartTime":"5:35:00 PM","sessionEndTime":"5:40:00 PM","sessionPerson":"562752","firstName":"Tanya M.","lastName":"Wildes"},{"sessionId":"12024","sessionTitle":"Hemoglobin Thresholds and Population Health ","sessionStartTime":"1:05:00 PM","sessionEndTime":"2:55:00 PM","sessionPerson":"477980","firstName":"Dorine W.","lastName":"Swinkels"},{"sessionId":"12026","sessionTitle":"Panel Discussion/Questions","sessionStartTime":"5:20:00 PM","sessionEndTime":"5:35:00 PM","sessionPerson":"567659","firstName":"Marlise R.","lastName":"Luskin"},{"sessionId":"12026","sessionTitle":"Panel Discussion/Questions","sessionStartTime":"5:20:00 PM","sessionEndTime":"5:35:00 PM","sessionPerson":"566402","firstName":"Paul A.","lastName":"Hamlin"},{"sessionId":"12026","sessionTitle":"Panel Discussion/Questions","sessionStartTime":"5:20:00 PM","sessionEndTime":"5:35:00 PM","sessionPerson":"569379","firstName":"Raul","lastName":"Cordoba"},{"sessionId":"12032","sessionTitle":"Panel Discussion","sessionStartTime":"2:05:00 PM","sessionEndTime":"2:35:00 PM","sessionPerson":"601264","firstName":"Hanlee","lastName":"Ji"},{"sessionId":"12032","sessionTitle":"Panel Discussion","sessionStartTime":"2:05:00 PM","sessionEndTime":"2:35:00 PM","sessionPerson":"601265","firstName":"Michael","lastName":"Angelo"},{"sessionId":"12033","sessionTitle":"Panel Discussion","sessionStartTime":"3:35:00 PM","sessionEndTime":"4:05:00 PM","sessionPerson":"561713","firstName":"June Helen","lastName":"Myklebust"},{"sessionId":"12033","sessionTitle":"Panel Discussion","sessionStartTime":"3:35:00 PM","sessionEndTime":"4:05:00 PM","sessionPerson":"601271","firstName":"Paul","lastName":"Sondel"},{"sessionId":"12034","sessionTitle":"Panel Discussion","sessionStartTime":"5:05:00 PM","sessionEndTime":"5:35:00 PM","sessionPerson":"587220","firstName":"Rajat","lastName":"Bannerji"},{"sessionId":"12034","sessionTitle":"Panel Discussion","sessionStartTime":"5:05:00 PM","sessionEndTime":"5:35:00 PM","sessionPerson":"589435","firstName":"Renier J.","lastName":"Brentjens"},{"sessionId":"12035","sessionTitle":"Closing Remarks ","sessionStartTime":"5:35:00 PM","sessionEndTime":"5:40:00 PM","sessionPerson":"565946","firstName":"Stephen M","lastName":"Ansell"},{"sessionId":"12035","sessionTitle":"Closing Remarks ","sessionStartTime":"5:35:00 PM","sessionEndTime":"5:40:00 PM","sessionPerson":"573876","firstName":"Ronald","lastName":"Levy"},{"sessionId":"12037","sessionTitle":"Late-Breaking Abstracts Session","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"533488","firstName":"Adam","lastName":"Cuker"},{"sessionId":"12037","sessionTitle":"Late-Breaking Abstracts Session","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"575112","firstName":"Laurie H.","lastName":"Sehn"},{"sessionId":"12040","sessionTitle":"Hemoglobin Thresholds and Clinical Medicine","sessionStartTime":"3:10:00 PM","sessionEndTime":"4:30:00 PM","sessionPerson":"553091","firstName":"Sant-Rayn","lastName":"Pasricha"},{"sessionId":"12041","sessionTitle":"Conclusions and Study Needs","sessionStartTime":"4:30:00 PM","sessionEndTime":"4:40:00 PM","sessionPerson":"601277","firstName":"Maria Nieves","lastName":"Garcia-Casal"},{"sessionId":"12041","sessionTitle":"Conclusions and Study Needs","sessionStartTime":"4:30:00 PM","sessionEndTime":"4:40:00 PM","sessionPerson":"601278","firstName":"Andrea","lastName":"Sharma"},{"sessionId":"12042","sessionTitle":"Closing Remarks ","sessionStartTime":"4:40:00 PM","sessionEndTime":"4:45:00 PM","sessionPerson":"553091","firstName":"Sant-Rayn","lastName":"Pasricha"},{"sessionId":"12042","sessionTitle":"Closing Remarks ","sessionStartTime":"4:40:00 PM","sessionEndTime":"4:45:00 PM","sessionPerson":"477980","firstName":"Dorine W.","lastName":"Swinkels"},{"sessionId":"12046","sessionTitle":"NHLBI Presentation ","sessionStartTime":"3:25:00 PM","sessionEndTime":"3:35:00 PM","sessionPerson":"601298","firstName":"John W.","lastName":"Thomas"},{"sessionId":"12047","sessionTitle":"NIDDK Presentation","sessionStartTime":"3:35:00 PM","sessionEndTime":"3:45:00 PM","sessionPerson":"601297","firstName":"Terry Rogers","lastName":"Bishop"}]
